CHEBI ONTOLOGY - ANNOTATIONS |
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
Term: | triphenyl phosphate |
|
Accession: | CHEBI:35033
|
browse the term
|
Definition: | An aryl phosphate resulting from the formal condensation of phosphoric acid with 3 mol eq. of phenol. |
Synonyms: | related_synonym: | Formula=C18H15O4P; InChI=1S/C18H15O4P/c19-23(20-16-10-4-1-5-11-16,21-17-12-6-2-7-13-17)22-18-14-8-3-9-15-18/h1-15H; InChIKey=XZZNDPSIHUTMOC-UHFFFAOYSA-N; Phosphoric acid, triphenyl ester; SMILES=O=P(Oc1ccccc1)(Oc1ccccc1)Oc1ccccc1; TPP; Triphenoxyphosphine oxide; Triphenylphosphate |
| xref: | Beilstein:1888236; CAS:115-86-6; KEGG:C14235 |
| xref_mesh: | MESH:C005445 |
| xref: | PMID:24316320; PMID:24395120; Reaxys:1888236; Wikipedia:Triphenyl_phosphate |
|
|
|
G |
Aacs |
acetoacetyl-CoA synthetase |
increases expression |
EXP |
triphenyl phosphate results in increased expression of AACS mRNA |
CTD |
PMID:30589522 |
|
NCBI chr12:31,113,098...31,156,411
Ensembl chr12:31,113,098...31,160,954
|
|
G |
Abca1 |
ATP binding cassette subfamily A member 1 |
decreases expression |
ISO |
triphenyl phosphate results in decreased expression of ABCA1 mRNA |
CTD |
PMID:31724879 |
|
NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170
|
|
G |
Abcb11 |
ATP binding cassette subfamily B member 11 |
multiple interactions |
ISO |
[tris(1,3-dichloro-2-propyl)phosphate co-treated with Tritolyl Phosphates co-treated with triphenyl phosphate] results in increased expression of ABCB11 mRNA |
CTD |
PMID:32360330 |
|
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ABCB1A mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcb4 |
ATP binding cassette subfamily B member 4 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of ABCB4 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 4:25,150,998...25,209,489
Ensembl chr 4:25,151,953...25,209,202
|
|
G |
Abcb9 |
ATP binding cassette subfamily B member 9 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of ABCB9 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr12:32,499,225...32,531,932
Ensembl chr12:32,499,225...32,531,931
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ABCC2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Abcc3 |
ATP binding cassette subfamily C member 3 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ABCC3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595
|
|
G |
Abcc4 |
ATP binding cassette subfamily C member 4 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ABCC4 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr15:95,541,186...95,774,898
Ensembl chr15:95,542,315...95,774,283
|
|
G |
Abcd2 |
ATP binding cassette subfamily D member 2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ABCD2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 7:122,263,034...122,311,642
Ensembl chr 7:122,263,032...122,311,642
|
|
G |
Abcg1 |
ATP binding cassette subfamily G member 1 |
multiple interactions decreases expression |
ISO |
triphenyl phosphate inhibits the reaction [T0901317 results in increased expression of ABCG1 mRNA] triphenyl phosphate results in decreased expression of ABCG1 mRNA |
CTD |
PMID:31724879 |
|
NCBI chr20:9,126,687...9,182,948
Ensembl chr20:9,126,687...9,182,948
|
|
G |
Abcg5 |
ATP binding cassette subfamily G member 5 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of ABCG5 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 6:9,965,118...9,990,563
Ensembl chr 6:9,965,118...9,990,563
|
|
G |
Abcg8 |
ATP binding cassette subfamily G member 8 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of ABCG8 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 6:9,945,629...9,964,912
Ensembl chr 6:9,945,629...9,964,912
|
|
G |
Abhd1 |
abhydrolase domain containing 1 |
affects expression |
EXP |
triphenyl phosphate affects the expression of ABHD1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 6:25,422,526...25,427,514
Ensembl chr 6:25,422,526...25,427,514
|
|
G |
Abhd5 |
abhydrolase domain containing 5, lysophosphatidic acid acyltransferase |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ABHD5 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 8:122,000,241...122,026,447
Ensembl chr 8:122,000,389...122,026,447
|
|
G |
Abi3bp |
ABI family member 3 binding protein |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of ABI3BP mRNA |
CTD |
PMID:30589522 |
|
NCBI chr11:43,912,187...44,128,888
Ensembl chr11:43,913,043...44,128,929
|
|
G |
Ablim1 |
actin-binding LIM protein 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ABLIM1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:256,084,293...256,372,075
Ensembl chr 1:256,084,297...256,371,969
|
|
G |
Ablim3 |
actin binding LIM protein family, member 3 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of ABLIM3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr18:55,256,135...55,376,629
Ensembl chr18:55,257,583...55,376,380
|
|
G |
Acaca |
acetyl-CoA carboxylase alpha |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ACACA mRNA |
CTD |
PMID:30589522 |
|
NCBI chr10:69,014,261...69,276,453
Ensembl chr10:69,014,170...69,276,457
|
|
G |
Acad9 |
acyl-CoA dehydrogenase family, member 9 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ACAD9 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:118,943,170...118,966,150
Ensembl chr 2:118,943,174...118,966,547
|
|
G |
Acat2 |
acetyl-CoA acetyltransferase 2 |
affects expression |
EXP |
triphenyl phosphate affects the expression of ACAT2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:47,695,833...47,713,879
Ensembl chr 1:47,695,788...47,752,821
|
|
G |
Acer2 |
alkaline ceramidase 2 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of ACER2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 5:101,391,830...101,442,615
Ensembl chr 5:101,391,885...101,442,614
|
|
G |
Acly |
ATP citrate lyase |
affects expression |
EXP |
triphenyl phosphate affects the expression of ACLY mRNA |
CTD |
PMID:30589522 |
|
NCBI chr10:85,412,045...85,464,253
Ensembl chr10:85,412,049...85,463,320
|
|
G |
Aco1 |
aconitase 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ACO1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 5:55,259,841...55,315,872
Ensembl chr 5:55,259,827...55,316,391
|
|
G |
Acot4 |
acyl-CoA thioesterase 4 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of ACOT4 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 6:103,668,699...103,674,037
Ensembl chr 6:103,668,753...103,673,917
|
|
G |
Acox3 |
acyl-CoA oxidase 3, pristanoyl |
affects expression |
EXP |
triphenyl phosphate affects the expression of ACOX3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr14:75,133,986...75,176,767
Ensembl chr14:75,094,676...75,176,205
|
|
G |
Acsl5 |
acyl-CoA synthetase long-chain family member 5 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of ACSL5 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:254,289,513...254,336,608
Ensembl chr 1:254,292,521...254,336,607
|
|
G |
Acsm2 |
acyl-CoA synthetase medium-chain family member 2 |
affects expression |
EXP |
triphenyl phosphate affects the expression of ACSM2A mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:173,916,368...173,955,116
Ensembl chr 1:173,916,368...173,955,116
|
|
G |
Acsm3 |
acyl-CoA synthetase medium-chain family member 3 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of ACSM3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:174,133,260...174,159,966
Ensembl chr 1:174,133,288...174,160,184
|
|
G |
Acsm5 |
acyl-CoA synthetase medium-chain family member 5 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ACSM5 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:173,870,873...173,896,838
Ensembl chr 1:173,863,041...173,898,588
|
|
G |
Acss2 |
acyl-CoA synthetase short-chain family member 2 |
affects expression |
EXP |
triphenyl phosphate affects the expression of ACSS2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 3:144,003,808...144,047,452
Ensembl chr 3:144,004,336...144,059,675
|
|
G |
Actg1 |
actin, gamma 1 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of ACTG1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr10:105,619,738...105,622,587
Ensembl chr10:105,619,737...105,624,232
|
|
G |
Acy3 |
aminoacylase 3 |
affects expression |
EXP |
triphenyl phosphate affects the expression of ACY3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:201,279,751...201,285,803
Ensembl chr 1:201,279,851...201,283,175
|
|
G |
Acyp1 |
acylphosphatase 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ACYP1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 6:104,919,162...104,932,348
Ensembl chr 6:104,919,162...104,932,387
|
|
G |
Acyp2 |
acylphosphatase 2 |
affects expression |
EXP |
triphenyl phosphate affects the expression of ACYP2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr14:104,201,894...104,371,415
Ensembl chr14:104,201,895...104,371,386
|
|
G |
Adam11 |
ADAM metallopeptidase domain 11 |
affects expression |
EXP |
triphenyl phosphate affects the expression of ADAM11 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr10:87,724,115...87,742,773
Ensembl chr10:87,724,234...87,741,562
|
|
G |
Adamts1 |
ADAM metallopeptidase with thrombospondin type 1 motif, 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ADAMTS1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr11:24,932,227...24,941,068
Ensembl chr11:24,931,761...24,941,103
|
|
G |
Adamts7 |
ADAM metallopeptidase with thrombospondin type 1 motif, 7 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ADAMTS7 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 8:90,704,727...90,744,331
Ensembl chr 8:90,704,727...90,744,328
|
|
G |
Adamts9 |
ADAM metallopeptidase with thrombospondin type 1 motif, 9 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of ADAMTS9 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 4:125,290,633...125,462,988
Ensembl chr 4:125,291,490...125,462,929
|
|
G |
Adgre1 |
adhesion G protein-coupled receptor E1 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of ADGRE1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 9:2,242,476...2,398,000
Ensembl chr 9:2,242,474...2,398,000
|
|
G |
Adgrg2 |
adhesion G protein-coupled receptor G2 |
affects expression |
EXP |
triphenyl phosphate affects the expression of ADGRG2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr X:34,297,402...34,422,590
Ensembl chr X:34,297,402...34,422,609
|
|
G |
Adh1 |
alcohol dehydrogenase 1C (class I), gamma polypeptide |
affects expression |
EXP |
triphenyl phosphate affects the expression of ADH1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:226,797,303...226,808,892
Ensembl chr 2:226,797,303...226,808,892
|
|
G |
Adh4 |
alcohol dehydrogenase 4 (class II), pi polypeptide |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ADH4 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:226,948,717...226,966,747
Ensembl chr 2:226,947,466...226,987,591
|
|
G |
Adh7 |
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide |
affects expression |
EXP |
triphenyl phosphate affects the expression of ADH7 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:226,748,724...226,763,183
Ensembl chr 2:226,741,788...226,763,182
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
increases expression multiple interactions |
ISO |
triphenyl phosphate results in increased expression of ADIPOQ mRNA [triphenyl phosphate co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA; [triphenyl phosphate co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased secretion of ADIPOQ protein |
CTD |
PMID:28934090 PMID:34323617 |
|
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
|
|
G |
Adm |
adrenomedullin |
multiple interactions |
ISO |
[tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in decreased expression of ADM mRNA |
CTD |
PMID:33367866 |
|
NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:164,745,466...164,747,654
|
|
G |
Adm2 |
adrenomedullin 2 |
multiple interactions |
ISO |
[tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in increased expression of ADM2 mRNA |
CTD |
PMID:33367866 |
|
NCBI chr 7:120,393,219...120,394,965
Ensembl chr 7:120,393,179...120,396,331
|
|
G |
Adra2b |
adrenoceptor alpha 2B |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of ADRA2B mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 3:114,585,174...114,589,220
Ensembl chr 3:114,585,169...114,589,355
|
|
G |
Adss1 |
adenylosuccinate synthase 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ADSSL1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 6:131,679,795...131,702,012
Ensembl chr 6:131,679,701...131,701,998
|
|
G |
Afg2a |
AFG2 AAA ATPase homolog A |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of AFG2A mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:120,306,412...120,497,707
Ensembl chr 2:120,306,412...120,497,705
|
|
G |
Afmid |
arylformamidase |
affects expression |
EXP |
triphenyl phosphate affects the expression of AFMID mRNA |
CTD |
PMID:30589522 |
|
NCBI chr10:103,046,129...103,061,718
Ensembl chr10:103,046,180...103,061,718
|
|
G |
Agrp |
agouti related neuropeptide |
multiple interactions |
ISO |
[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of AGRP mRNA; [tris(1,3-dichloro-2-propyl)phosphate co-treated with Tritolyl Phosphates co-treated with triphenyl phosphate] results in increased expression of AGRP mRNA |
CTD |
PMID:29112739 PMID:32360330 |
|
NCBI chr19:33,447,992...33,523,068
Ensembl chr19:33,447,992...33,449,584
|
|
G |
Agtr1a |
angiotensin II receptor, type 1a |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of AGTR1A mRNA |
CTD |
PMID:30589522 |
|
NCBI chr17:34,173,446...34,226,892
Ensembl chr17:34,174,429...34,226,946
|
|
G |
Agxt |
alanine--glyoxylate aminotransferase |
affects expression |
EXP |
triphenyl phosphate affects the expression of AGXT mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 9:93,675,384...93,685,337
Ensembl chr 9:93,675,384...93,685,336
|
|
G |
Ak3 |
adenylate kinase 3 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of AK3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:226,737,472...226,764,647
Ensembl chr 1:226,739,318...226,764,625
|
|
G |
Ak4 |
adenylate kinase 4 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of AK4 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 5:116,039,222...116,099,064
Ensembl chr 5:116,039,616...116,098,618
|
|
G |
Akap13 |
A-kinase anchoring protein 13 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of AKAP13 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:129,313,183...129,619,647
Ensembl chr 1:129,314,402...129,619,646
|
|
G |
Akap2 |
A-kinase anchoring protein 2 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of AKAP2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 5:72,536,986...72,648,524
Ensembl chr 5:72,181,718...72,648,524
|
|
G |
Akr1b7 |
aldo-keto reductase family 1, member B7 |
affects expression |
EXP |
triphenyl phosphate affects the expression of AKR1B7 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 4:63,053,560...63,100,934
Ensembl chr 4:63,076,800...63,089,502
|
|
G |
Akr7a2 |
aldo-keto reductase family 7, member A2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of AKR7A2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 5:151,552,375...151,560,914
Ensembl chr 5:151,552,343...151,560,909
|
|
G |
Akr7a3 |
aldo-keto reductase family 7 member A3 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of AKR7A3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 5:151,590,968...151,601,394
Ensembl chr 5:151,584,479...151,601,394
|
|
G |
Alas1 |
5'-aminolevulinate synthase 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ALAS1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 8:106,876,514...106,889,852
Ensembl chr 8:106,876,514...106,889,917
|
|
G |
Alas2 |
5'-aminolevulinate synthase 2 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of ALAS2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr X:19,463,146...19,486,526
Ensembl chr X:19,463,171...19,486,519
|
|
G |
Alb |
albumin |
decreases secretion |
EXP |
triphenyl phosphate results in decreased secretion of ALB protein |
CTD |
PMID:30589522 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Alcam |
activated leukocyte cell adhesion molecule |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ALCAM mRNA |
CTD |
PMID:30589522 |
|
NCBI chr11:48,336,123...48,536,296
Ensembl chr11:48,336,169...48,537,954
|
|
G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ALDH1A1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
|
|
G |
Aldh1a3 |
aldehyde dehydrogenase 1 family, member A3 |
affects expression |
EXP |
triphenyl phosphate affects the expression of ALDH1A3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:119,982,272...120,017,416
Ensembl chr 1:119,982,277...120,017,436
|
|
G |
Amigo2 |
adhesion molecule with Ig like domain 2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of AMIGO2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 7:128,391,493...128,394,589
Ensembl chr 7:128,390,412...128,394,695
|
|
G |
Amz1 |
archaelysin family metallopeptidase 1 |
decreases expression |
ISO |
triphenyl phosphate results in decreased expression of AMZ1 mRNA |
CTD |
PMID:28934090 |
|
NCBI chr12:13,886,533...13,924,275
Ensembl chr12:13,891,123...13,909,783
|
|
G |
Angptl4 |
angiopoietin-like 4 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of ANGPTL4 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 7:14,550,288...14,557,797
Ensembl chr 7:14,550,311...14,556,519
|
|
G |
Ankrd33b |
ankyrin repeat domain 33B |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of ANKRD33B mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:82,277,604...82,359,420
Ensembl chr 2:82,283,108...82,358,872
|
|
G |
Ankrd46 |
ankyrin repeat domain 46 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ANKRD46 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 7:67,647,202...67,668,180
Ensembl chr 7:67,647,204...67,668,132
|
|
G |
Anxa1 |
annexin A1 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of ANXA1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343
|
|
G |
Anxa3 |
annexin A3 |
affects expression |
EXP |
triphenyl phosphate affects the expression of ANXA3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr14:12,727,708...12,781,717
Ensembl chr14:12,719,795...12,781,617
|
|
G |
Anxa7 |
annexin A7 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ANXA7 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr15:3,821,798...3,849,659
Ensembl chr15:3,821,845...3,849,385
|
|
G |
Aox1 |
aldehyde oxidase 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of AOX1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 9:59,579,621...59,658,772
Ensembl chr 9:59,579,649...59,658,770
|
|
G |
Ap3m1 |
adaptor related protein complex 3 subunit mu 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of AP3M1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr15:3,246,616...3,264,846
Ensembl chr15:3,246,926...3,264,844
|
|
G |
Aplf |
aprataxin and PNKP like factor |
increases expression |
EXP |
triphenyl phosphate results in increased expression of APLF mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 4:120,070,471...120,122,656
Ensembl chr 4:120,070,471...120,122,633
|
|
G |
Aplnr |
apelin receptor |
multiple interactions |
ISO |
[tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in decreased expression of APLNR mRNA |
CTD |
PMID:33367866 |
|
NCBI chr 3:70,217,407...70,221,052
Ensembl chr 3:70,217,385...70,221,050
|
|
G |
Apoa4 |
apolipoprotein A4 |
affects expression |
EXP |
triphenyl phosphate affects the expression of APOA4 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 8:46,539,083...46,541,464
Ensembl chr 8:46,539,082...46,541,469
|
|
G |
Apoe |
apolipoprotein E |
affects response to substance |
ISO |
APOE protein affects the susceptibility to triphenyl phosphate |
CTD |
PMID:31724879 |
|
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
|
|
G |
App |
amyloid beta precursor protein |
increases expression |
EXP |
triphenyl phosphate results in increased expression of APP mRNA |
CTD |
PMID:30589522 |
|
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Aqp7 |
aquaporin 7 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of AQP7 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 5:56,171,649...56,186,642
Ensembl chr 5:56,172,519...56,186,642
|
|
G |
Aqp9 |
aquaporin 9 |
affects expression |
EXP |
triphenyl phosphate affects the expression of AQP9 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 8:71,797,231...71,837,485
Ensembl chr 8:71,797,234...71,837,395
|
|
G |
Ar |
androgen receptor |
affects binding decreases activity multiple interactions |
EXP ISO |
triphenyl phosphate binds to AR protein triphenyl phosphate results in decreased activity of AR protein triphenyl phosphate binds to and results in decreased activity of AR protein; triphenyl phosphate inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; triphenyl phosphate inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein]; triphenyl phosphate metabolite inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein] |
CTD |
PMID:14565775 PMID:23398518 PMID:24051214 PMID:26778350 PMID:28728110 PMID:33049310 More...
|
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Arhgap24 |
Rho GTPase activating protein 24 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ARHGAP24 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr14:6,800,631...7,184,001
Ensembl chr14:6,800,631...7,183,823
|
|
G |
Arhgef26 |
Rho guanine nucleotide exchange factor 26 |
affects expression |
EXP |
triphenyl phosphate affects the expression of ARHGEF26 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:146,740,336...146,850,918
Ensembl chr 2:146,739,631...146,850,819
|
|
G |
Arid5b |
AT-rich interaction domain 5B |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ARID5B mRNA |
CTD |
PMID:30589522 |
|
NCBI chr20:20,307,731...20,490,746
Ensembl chr20:20,307,731...20,487,433
|
|
G |
Armc9 |
armadillo repeat containing 9 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ARMC9 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 9:86,802,791...86,928,860
Ensembl chr 9:86,802,868...86,928,860
|
|
G |
Arpp19 |
cAMP-regulated phosphoprotein 19 |
affects expression |
EXP |
triphenyl phosphate affects the expression of ARPP19 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 8:75,779,640...75,802,474
Ensembl chr 8:75,779,523...75,802,452
|
|
G |
Arsb |
arylsulfatase B |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ARSB mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:25,002,210...25,162,675
Ensembl chr 2:25,002,346...25,162,671
|
|
G |
Arsl |
arylsulfatase L |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ARSL mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:119,038,803...119,047,579
Ensembl chr 2:119,038,921...119,046,846
|
|
G |
Asb5 |
ankyrin repeat and SOCS box-containing 5 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ASB5 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr16:37,237,869...37,305,207
Ensembl chr16:37,235,405...37,278,109
|
|
G |
Asl |
argininosuccinate lyase |
affects expression |
EXP |
triphenyl phosphate affects the expression of ASL mRNA |
CTD |
PMID:30589522 |
|
NCBI chr12:26,659,664...26,677,136
Ensembl chr12:26,659,565...26,679,662
|
|
G |
Asns |
asparagine synthetase (glutamine-hydrolyzing) |
increases expression multiple interactions |
EXP ISO |
triphenyl phosphate results in increased expression of ASNS mRNA [tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in increased expression of ASNS mRNA |
CTD |
PMID:30589522 PMID:33367866 |
|
NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423
|
|
G |
Atf4 |
activating transcription factor 4 |
increases expression multiple interactions |
EXP ISO |
triphenyl phosphate results in increased expression of ATF4 mRNA [tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in increased expression of ATF4 mRNA |
CTD |
PMID:30589522 PMID:33367866 |
|
NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:111,804,183...111,806,446
|
|
G |
Atf6 |
activating transcription factor 6 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ATF6 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177
|
|
G |
Atoh8 |
atonal bHLH transcription factor 8 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of ATOH8 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 4:104,259,992...104,292,168
Ensembl chr 4:104,259,992...104,292,168
|
|
G |
Atp6v1c2 |
ATPase H+ transporting V1 subunit C2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ATP6V1C2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 6:40,080,545...40,144,199
Ensembl chr 6:40,080,547...40,120,028
|
|
G |
Atp8a1 |
ATPase phospholipid transporting 8A1 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of ATP8A1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr14:40,315,013...40,557,572
Ensembl chr14:40,315,049...40,554,611
|
|
G |
Atp8b1 |
ATPase phospholipid transporting 8B1 |
affects expression |
EXP |
triphenyl phosphate affects the expression of ATP8B1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr18:58,016,382...58,157,213
Ensembl chr18:58,018,268...58,157,396
|
|
G |
Atrn |
attractin |
affects expression |
EXP |
triphenyl phosphate affects the expression of ATRN mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 3:118,110,320...118,244,326
Ensembl chr 3:118,110,229...118,244,322
|
|
G |
Aurkb |
aurora kinase B |
affects expression |
EXP |
triphenyl phosphate affects the expression of AURKB mRNA |
CTD |
PMID:30589522 |
|
NCBI chr10:53,744,290...53,750,831
Ensembl chr10:53,745,142...53,750,837
|
|
G |
Avpi1 |
arginine vasopressin-induced 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of AVPI1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:240,930,236...240,936,154
Ensembl chr 1:240,930,236...240,936,154
|
|
G |
Avpr1a |
arginine vasopressin receptor 1A |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of AVPR1A mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 7:58,114,306...58,118,230
Ensembl chr 7:58,114,284...58,122,215
|
|
G |
Axin2 |
axin 2 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of AXIN2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr10:93,893,830...93,927,042
Ensembl chr10:93,899,245...93,926,231
|
|
G |
Axl |
Axl receptor tyrosine kinase |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of AXL mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:81,265,656...81,296,278
Ensembl chr 1:81,265,088...81,296,265
|
|
G |
B3gnt2 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of B3GNT2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr14:96,808,473...96,833,674
Ensembl chr14:96,806,664...96,835,273
|
|
G |
Bbc3 |
Bcl-2 binding component 3 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of BBC3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:77,013,281...77,022,509
Ensembl chr 1:77,014,543...77,022,509
|
|
G |
Bcar3 |
BCAR3 adaptor protein, NSP family member |
increases expression |
EXP |
triphenyl phosphate results in increased expression of BCAR3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:210,525,260...210,638,674
Ensembl chr 2:210,525,260...210,638,798
|
|
G |
Bcl2a1 |
BCL2-related protein A1 |
affects expression |
EXP |
triphenyl phosphate affects the expression of BCL2A1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 8:89,716,914...89,724,998
Ensembl chr 8:89,716,914...89,724,998
|
|
G |
Bcl2l11 |
Bcl2-like 11 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of BCL2L11 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 3:115,366,783...115,404,068
Ensembl chr 3:115,366,646...115,404,068
|
|
G |
Bcl6b |
BCL6B, transcription repressor |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of BCL6B mRNA |
CTD |
PMID:30589522 |
|
NCBI chr10:54,940,908...54,947,022
Ensembl chr10:54,940,909...54,945,974
|
|
G |
Bdh2 |
3-hydroxybutyrate dehydrogenase 2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of BDH2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:223,702,410...223,723,076
Ensembl chr 2:223,702,412...223,723,072
|
|
G |
Bgn |
biglycan |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of BGN mRNA |
CTD |
PMID:30589522 |
|
NCBI chr X:151,197,296...151,209,458
Ensembl chr X:151,197,273...151,209,461
|
|
G |
Bhmt |
betaine-homocysteine S-methyltransferase |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of BHMT mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:24,859,871...24,879,449
Ensembl chr 2:24,859,873...24,879,742
|
|
G |
Blm |
BLM RecQ like helicase |
increases expression |
EXP |
triphenyl phosphate results in increased expression of BLM mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:134,409,832...134,496,073
Ensembl chr 1:134,409,857...134,484,312
|
|
G |
Bmal1 |
basic helix-loop-helix ARNT like 1 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of BMAL1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:167,331,756...167,430,235
Ensembl chr 1:167,331,633...167,430,231
|
|
G |
Bpifb4 |
BPI fold containing family B, member 4 |
decreases expression |
ISO |
triphenyl phosphate results in decreased expression of BPIFB4 mRNA |
CTD |
PMID:28934090 |
|
NCBI chr 3:142,423,571...142,448,044
Ensembl chr 3:142,400,976...142,448,044
|
|
G |
Bub1 |
BUB1 mitotic checkpoint serine/threonine kinase |
increases expression |
EXP |
triphenyl phosphate results in increased expression of BUB1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 3:115,020,254...115,051,650
Ensembl chr 3:115,020,254...115,051,650
|
|
G |
C1qa |
complement C1q A chain |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of C1QA mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 5:149,133,635...149,136,482
Ensembl chr 5:149,133,636...149,136,534
|
|
G |
C1qc |
complement C1q C chain |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of C1QC mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 5:149,127,424...149,130,732
Ensembl chr 5:149,127,415...149,131,017
|
|
G |
C2h4orf46 |
similar to human chromosome 4 open reading frame 46 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of C2H4ORF46 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:164,762,994...164,766,126
Ensembl chr 2:164,762,960...164,766,128
|
|
G |
C3ar1 |
complement C3a receptor 1 |
multiple interactions |
ISO |
[tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in decreased expression of C3AR1 mRNA |
CTD |
PMID:33367866 |
|
NCBI chr 4:156,074,747...156,084,680
Ensembl chr 4:156,075,389...156,084,701
|
|
G |
C8h11orf54 |
similar to human chromosome 11 open reading frame 54 |
affects expression |
EXP |
triphenyl phosphate affects the expression of C8H11ORF54 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 8:12,123,839...12,146,412
Ensembl chr 8:12,123,823...12,146,473
|
|
G |
Cabcoco1 |
ciliary associated calcium binding coiled-coil 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CABCOCO1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr20:20,058,492...20,167,973
Ensembl chr20:20,058,454...20,167,725
|
|
G |
Cacna1g |
calcium voltage-gated channel subunit alpha1 G |
multiple interactions |
ISO |
[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of CACNA1G mRNA; ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of CACNA1G mRNA] |
CTD |
PMID:29112739 |
|
NCBI chr10:79,354,998...79,422,960
Ensembl chr10:79,355,008...79,422,752
|
|
G |
Cacna1h |
calcium voltage-gated channel subunit alpha1 H |
multiple interactions |
ISO |
[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of CACNA1H mRNA; ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of CACNA1H mRNA] |
CTD |
PMID:29112739 |
|
NCBI chr10:14,390,104...14,448,204
Ensembl chr10:14,390,113...14,448,376
|
|
G |
Cacna1i |
calcium voltage-gated channel subunit alpha1 I |
multiple interactions |
ISO |
[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of CACNA1I mRNA; ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of CACNA1I mRNA] |
CTD |
PMID:29112739 |
|
NCBI chr 7:111,835,996...111,947,418
Ensembl chr 7:111,836,012...111,944,688
|
|
G |
Cadm1 |
cell adhesion molecule 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CADM1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 8:47,847,836...48,178,703
Ensembl chr 8:47,847,325...48,182,833
|
|
G |
Calr3 |
calreticulin 3 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CALR3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr16:17,396,064...17,423,166
Ensembl chr16:17,396,247...17,423,015
|
|
G |
Caprin2 |
caprin family member 2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CAPRIN2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 4:181,806,105...181,860,754
Ensembl chr 4:181,806,575...181,860,830
|
|
G |
Car1 |
carbonic anhydrase 1 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CA1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:86,829,436...86,872,209
Ensembl chr 2:86,861,897...86,872,208
|
|
G |
Car3 |
carbonic anhydrase 3 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CAR3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:86,770,418...86,780,011
Ensembl chr 2:86,770,420...86,784,280
|
|
G |
Cartpt |
CART prepropeptide |
multiple interactions |
ISO |
[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in decreased expression of CARTPT mRNA; ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in decreased expression of CARTPT mRNA] |
CTD |
PMID:29112739 |
|
NCBI chr 2:31,255,098...31,257,452
Ensembl chr 2:31,255,098...31,290,713
|
|
G |
Casp3 |
caspase 3 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CASP3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp4 |
caspase 4 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CASP4 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 8:2,599,017...2,635,097
Ensembl chr 8:2,598,876...2,635,092
|
|
G |
Cat |
catalase |
increases expression increases activity |
ISO EXP |
triphenyl phosphate results in increased expression of CAT mRNA; triphenyl phosphate results in increased expression of CAT protein triphenyl phosphate results in increased activity of CAT protein |
CTD |
PMID:26049154 PMID:26183808 PMID:30974155 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cav2 |
caveolin 2 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CAV2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 4:45,616,766...45,624,144
Ensembl chr 4:45,616,712...45,624,244
|
|
G |
Cbr4 |
carbonyl reductase 4 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CBR4 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr16:28,629,928...28,684,230
Ensembl chr16:28,617,224...28,645,712
|
|
G |
Cbs |
cystathionine beta synthase |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CBS mRNA |
CTD |
PMID:30589522 |
|
NCBI chr20:9,708,089...9,732,623
Ensembl chr20:9,708,090...9,732,764
|
|
G |
Cbx5 |
chromobox 5 |
affects expression |
EXP |
triphenyl phosphate affects the expression of CBX5 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 7:134,333,165...134,376,102
Ensembl chr 7:134,331,335...134,375,022
|
|
G |
Cc2d2a |
coiled-coil and C2 domain containing 2A |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CC2D2A mRNA |
CTD |
PMID:30589522 |
|
NCBI chr14:67,349,004...67,435,883
Ensembl chr14:67,351,353...67,435,949
|
|
G |
Ccdc17 |
coiled-coil domain containing 17 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CCDC17 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 5:130,051,158...130,056,676
Ensembl chr 5:130,045,938...130,056,673
|
|
G |
Ccdc80 |
coiled-coil domain containing 80 |
affects expression |
EXP |
triphenyl phosphate affects the expression of CCDC80 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr11:55,685,165...55,718,827
Ensembl chr11:55,685,872...55,719,137
|
|
G |
Ccl24 |
C-C motif chemokine ligand 24 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CCL24 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr12:21,100,835...21,104,832
Ensembl chr12:21,100,835...21,104,893
|
|
G |
Ccl9 |
C-C motif chemokine ligand 9 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CCL6 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr10:68,366,486...68,371,408
Ensembl chr10:68,366,487...68,371,369
|
|
G |
Ccn2 |
cellular communication network factor 2 |
affects expression |
EXP |
triphenyl phosphate affects the expression of CCN2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
|
|
G |
Ccng2 |
cyclin G2 |
affects expression |
EXP |
triphenyl phosphate affects the expression of CCNG2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr14:14,804,321...14,812,819
Ensembl chr14:14,804,322...14,812,830
|
|
G |
Ccser2 |
coiled-coil serine-rich protein 2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CCSER2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr16:12,613,103...12,725,764
Ensembl chr16:12,613,103...12,725,738
|
|
G |
Cd14 |
CD14 molecule |
increases expression |
ISO |
triphenyl phosphate results in increased expression of CD14 mRNA |
CTD |
PMID:35752650 |
|
NCBI chr18:28,335,522...28,337,383
Ensembl chr18:28,335,340...28,337,261
|
|
G |
Cd163 |
CD163 molecule |
decreases expression increases expression |
EXP ISO |
triphenyl phosphate results in decreased expression of CD163 mRNA triphenyl phosphate results in increased expression of CD163 mRNA |
CTD |
PMID:30589522 PMID:35752650 |
|
NCBI chr 4:157,085,080...157,118,470
Ensembl chr 4:157,085,093...157,117,878
|
|
G |
Cd36 |
CD36 molecule |
multiple interactions |
ISO |
[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in decreased expression of CD36 mRNA; ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in decreased expression of CD36 mRNA] |
CTD |
PMID:29112739 |
|
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
|
|
G |
Cd46 |
CD46 molecule |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CD46 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr13:106,575,586...106,606,325
Ensembl chr13:106,574,858...106,660,445
|
|
G |
Cd5l |
Cd5 molecule-like |
affects expression |
EXP |
triphenyl phosphate affects the expression of CD5L mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:172,791,007...172,802,018
Ensembl chr 2:172,790,934...172,829,753
|
|
G |
Cd74 |
CD74 molecule |
affects expression |
EXP |
triphenyl phosphate affects the expression of CD74 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr18:54,256,757...54,266,003
Ensembl chr18:54,256,778...54,266,003
|
|
G |
Cd93 |
CD93 molecule |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CD93 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 3:135,891,859...135,898,378
Ensembl chr 3:135,891,859...135,898,378
|
|
G |
Cdc25b |
cell division cycle 25B |
affects expression |
EXP |
triphenyl phosphate affects the expression of CDC25B mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 3:118,407,127...118,417,272
Ensembl chr 3:118,407,128...118,417,272
|
|
G |
Cdc42ep3 |
CDC42 effector protein 3 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CDC42EP3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 6:15,710,894...15,731,366
Ensembl chr 6:15,708,730...15,732,721
|
|
G |
Cdh1 |
cadherin 1 |
decreases expression |
ISO |
triphenyl phosphate results in decreased expression of CDH1 mRNA |
CTD |
PMID:35776891 |
|
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Cdh2 |
cadherin 2 |
increases expression |
ISO |
triphenyl phosphate results in increased expression of CDH2 mRNA |
CTD |
PMID:35776891 |
|
NCBI chr18:7,776,704...7,990,934
Ensembl chr18:7,776,704...7,990,167
|
|
G |
Cdh5 |
cadherin 5 |
multiple interactions |
ISO |
[tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in decreased expression of CDH5 mRNA |
CTD |
PMID:33367866 |
|
NCBI chr19:815,415...854,478
Ensembl chr19:815,411...854,368
|
|
G |
Cdhr1 |
cadherin-related family member 1 |
increases expression |
ISO |
triphenyl phosphate results in increased expression of CDHR1 mRNA |
CTD |
PMID:28934090 |
|
NCBI chr16:12,843,436...12,863,321
Ensembl chr16:12,843,437...12,863,396
|
|
G |
Cdk14 |
cyclin-dependent kinase 14 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CDK14 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 4:28,666,688...29,258,865
Ensembl chr 4:28,666,843...29,258,861
|
|
G |
Cdkl2 |
cyclin dependent kinase like 2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CDKL2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr14:16,027,381...16,063,257
Ensembl chr14:16,028,363...16,063,252
|
|
G |
Cdkl4 |
cyclin-dependent kinase-like 4 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CDKL4 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 6:14,449,822...14,492,568
Ensembl chr 6:14,450,681...14,492,046
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CDKN1A mRNA |
CTD |
PMID:30589522 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn2aipnl |
CDKN2A interacting protein N-terminal like |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CDKN2AIPNL mRNA |
CTD |
PMID:30589522 |
|
NCBI chr10:36,231,134...36,240,569
Ensembl chr10:36,231,087...36,240,564
|
|
G |
Cdt1 |
chromatin licensing and DNA replication factor 1 |
affects expression |
EXP |
triphenyl phosphate affects the expression of CDT1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr19:50,620,713...50,625,659
Ensembl chr19:50,620,713...50,625,659
|
|
G |
Ceacam1 |
CEA cell adhesion molecule 1 |
affects expression |
EXP |
triphenyl phosphate affects the expression of CEACAM1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:81,043,595...81,060,050
Ensembl chr 1:81,043,595...81,059,992
|
|
G |
Cebpa |
CCAAT/enhancer binding protein alpha |
increases expression multiple interactions |
ISO |
triphenyl phosphate results in increased expression of CEBPA mRNA [1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with triphenyl phosphate analog] results in increased expression of CEBPA mRNA; [1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with triphenyl phosphate] results in increased expression of CEBPA mRNA |
CTD |
PMID:28163246 PMID:28437481 PMID:28934090 |
|
NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
|
|
G |
Cebpb |
CCAAT/enhancer binding protein beta |
increases expression |
ISO |
triphenyl phosphate results in increased expression of CEBPB mRNA |
CTD |
PMID:28163246 |
|
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
|
|
G |
Cebpd |
CCAAT/enhancer binding protein delta |
increases expression affects expression |
ISO EXP |
triphenyl phosphate results in increased expression of CEBPD mRNA triphenyl phosphate affects the expression of CEBPD mRNA |
CTD |
PMID:28163246 PMID:30589522 |
|
NCBI chr11:84,764,670...84,765,808
Ensembl chr11:84,764,565...84,765,829
|
|
G |
Cela1 |
chymotrypsin like elastase 1 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CELA1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 7:131,773,161...131,786,300
Ensembl chr 7:131,742,002...131,786,285
|
|
G |
Cenpk |
centromere protein K |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CENPK mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:35,360,132...35,421,372
Ensembl chr 2:35,360,132...35,385,706
|
|
G |
Cenpl |
centromere protein L |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CENPL mRNA |
CTD |
PMID:30589522 |
|
NCBI chr13:73,337,235...73,352,115
Ensembl chr13:73,337,257...73,352,114
|
|
G |
Cep104 |
centrosomal protein 104 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CEP104 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 5:164,534,773...164,567,260
Ensembl chr 5:164,534,782...164,567,248
|
|
G |
Cep164 |
centrosomal protein 164 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CEP164 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 8:46,070,901...46,134,511
Ensembl chr 8:46,071,076...46,134,336
|
|
G |
Cers6 |
ceramide synthase 6 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CERS6 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 3:53,630,636...53,879,692
Ensembl chr 3:53,630,959...53,876,848
|
|
G |
Ces1d |
carboxylesterase 1D |
multiple interactions decreases expression decreases activity |
ISO EXP |
triphenyl phosphate inhibits the reaction [CES1 protein results in increased metabolism of and results in increased activity of imidapril] triphenyl phosphate results in decreased expression of CES1D mRNA triphenyl phosphate results in decreased activity of CES1 protein |
CTD |
PMID:30589522 PMID:31268531 |
|
NCBI chr19:13,873,490...13,912,035
Ensembl chr19:13,796,623...13,912,035
|
|
G |
Cfap20 |
cilia and flagella associated protein 20 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CFAP20 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr19:9,608,851...9,622,562
Ensembl chr19:9,608,859...9,622,558
|
|
G |
Cftr |
CF transmembrane conductance regulator |
affects expression |
ISO |
triphenyl phosphate affects the expression of CFTR mRNA |
CTD |
PMID:36563926 |
|
NCBI chr 4:46,561,269...46,728,759
Ensembl chr 4:46,560,885...46,728,756
|
|
G |
Chac1 |
ChaC glutathione-specific gamma-glutamylcyclotransferase 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CHAC1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 3:106,342,302...106,345,526
Ensembl chr 3:106,342,302...106,345,526
|
|
G |
Chd9 |
chromodomain helicase DNA binding protein 9 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CHD9 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr19:15,941,535...16,146,220
Ensembl chr19:15,942,687...16,164,556
|
|
G |
Chka |
choline kinase alpha |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CHKA mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:201,076,804...201,125,517
Ensembl chr 1:201,076,860...201,125,516
|
|
G |
Chmp4c |
charged multivesicular body protein 4C |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CHMP4C mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:91,391,729...91,428,652
Ensembl chr 2:91,388,530...91,428,668
|
|
G |
Chrna4 |
cholinergic receptor nicotinic alpha 4 subunit |
multiple interactions |
ISO |
triphenyl phosphate inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein co-treated with CHRNB2 protein]] |
CTD |
PMID:22750351 |
|
NCBI chr 3:168,136,246...168,157,839
Ensembl chr 3:168,136,266...168,156,957
|
|
G |
Chrnb2 |
cholinergic receptor nicotinic beta 2 subunit |
multiple interactions |
ISO |
triphenyl phosphate inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein co-treated with CHRNB2 protein]] |
CTD |
PMID:22750351 |
|
NCBI chr 2:175,181,402...175,189,619
Ensembl chr 2:175,181,402...175,189,619
|
|
G |
Chsy1 |
chondroitin sulfate synthase 1 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CHSY1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:119,689,626...119,750,711
Ensembl chr 1:119,686,350...119,750,601
|
|
G |
Chuk |
component of inhibitor of nuclear factor kappa B kinase complex |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CHUK mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:242,959,539...242,995,066
Ensembl chr 1:242,959,760...242,995,065
|
|
G |
Cidea |
cell death-inducing DFFA-like effector a |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CIDEA mRNA |
CTD |
PMID:30589522 |
|
NCBI chr18:60,894,917...60,920,485
Ensembl chr18:60,894,874...60,920,481
|
|
G |
Cidec |
cell death-inducing DFFA-like effector c |
increases expression multiple interactions |
ISO |
triphenyl phosphate results in increased expression of CIDEC mRNA [triphenyl phosphate co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CIDEC mRNA |
CTD |
PMID:28934090 PMID:34323617 |
|
NCBI chr 4:146,569,288...146,582,173
Ensembl chr 4:146,569,289...146,582,173
|
|
G |
Cimap1b |
ciliary microtubule associated protein 1B |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of ODF3B mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 7:120,444,232...120,447,383
Ensembl chr 7:120,444,232...120,446,749
|
|
G |
Cish |
cytokine inducible SH2-containing protein |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CISH mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 8:107,972,306...107,977,254
Ensembl chr 8:107,972,306...107,977,250
|
|
G |
Ckb |
creatine kinase B |
increases expression |
ISO |
triphenyl phosphate results in increased expression of CKB mRNA |
CTD |
PMID:35776891 |
|
NCBI chr 6:130,729,420...130,732,301
Ensembl chr 6:130,729,423...130,732,315
|
|
G |
Clca2 |
chloride channel accessory 2 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CLCA2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:233,993,619...234,022,691
Ensembl chr 2:233,995,078...234,022,199
|
|
G |
Clcf1 |
cardiotrophin-like cytokine factor 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CLCF1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:201,507,763...201,517,607
Ensembl chr 1:201,507,859...201,517,605
|
|
G |
Clcn3 |
chloride voltage-gated channel 3 |
affects expression |
EXP |
triphenyl phosphate affects the expression of CLCN3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr16:29,127,419...29,200,133
Ensembl chr16:29,127,419...29,200,119
|
|
G |
Cldn1 |
claudin 1 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CLDN1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr11:74,421,569...74,436,728
Ensembl chr11:74,421,569...74,436,724
|
|
G |
Cldn14 |
claudin 14 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CLDN14 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr11:33,232,281...33,329,440
Ensembl chr11:33,232,220...33,329,171
|
|
G |
Cldn5 |
claudin 5 |
decreases expression |
ISO |
triphenyl phosphate results in decreased expression of CLDN5 mRNA |
CTD |
PMID:35752650 |
|
NCBI chr11:82,212,822...82,214,248
Ensembl chr11:82,211,475...82,214,992
|
|
G |
Clec4f |
C-type lectin domain family 4, member F |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CLEC4F mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 4:116,129,023...116,138,744
Ensembl chr 4:116,129,023...116,138,775
|
|
G |
Clock |
clock circadian regulator |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CLOCK mRNA |
CTD |
PMID:30589522 |
|
NCBI chr14:31,908,542...31,992,673
Ensembl chr14:31,908,566...31,990,400
|
|
G |
Clpx |
caseinolytic mitochondrial matrix peptidase chaperone subunit X |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CLPX mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 8:65,805,460...65,845,643
Ensembl chr 8:65,805,511...65,845,082
|
|
G |
Cmip |
c-Maf-inducing protein |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CMIP mRNA |
CTD |
PMID:30589522 |
|
NCBI chr19:45,304,597...45,510,653
Ensembl chr19:45,304,031...45,508,709
|
|
G |
Cmtm6 |
CKLF-like MARVEL transmembrane domain containing 6 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CMTM6 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 8:114,422,681...114,441,034
Ensembl chr 8:114,422,921...114,441,033
|
|
G |
Cmtm8 |
CKLF-like MARVEL transmembrane domain containing 8 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CMTM8 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 8:114,481,730...114,547,107
Ensembl chr 8:114,481,982...114,547,083
|
|
G |
Cndp2 |
carnosine dipeptidase 2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CNDP2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr18:78,039,924...78,057,030
Ensembl chr18:78,039,932...78,056,922
|
|
G |
Cnn1 |
calponin 1 |
decreases expression |
ISO |
triphenyl phosphate results in decreased expression of CNN1 mRNA |
CTD |
PMID:28934090 |
|
NCBI chr 8:20,632,434...20,641,097
Ensembl chr 8:20,632,338...20,641,098
|
|
G |
Cnnm2 |
cyclin and CBS domain divalent metal cation transport mediator 2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CNNM2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:245,643,682...245,769,542
Ensembl chr 1:245,643,768...245,763,286
|
|
G |
Cnp |
2',3'-cyclic nucleotide 3' phosphodiesterase |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CNP mRNA |
CTD |
PMID:30589522 |
|
NCBI chr10:85,511,164...85,517,723
Ensembl chr10:85,511,160...85,517,720
|
|
G |
Cobl |
cordon-bleu WH2 repeat protein |
increases expression |
EXP |
triphenyl phosphate results in increased expression of COBL mRNA |
CTD |
PMID:30589522 |
|
NCBI chr14:86,828,137...87,060,682
Ensembl chr14:86,828,139...87,060,800
|
|
G |
Cobll1 |
cordon-bleu WH2 repeat protein-like 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of COBLL1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 3:49,753,260...49,915,168
Ensembl chr 3:49,753,262...49,915,194
|
|
G |
Col10a1 |
collagen type X alpha 1 chain |
multiple interactions |
ISO |
[tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in decreased expression of COL10A1 mRNA |
CTD |
PMID:33367866 |
|
NCBI chr20:38,183,103...38,189,488
Ensembl chr20:38,182,494...38,189,494
|
|
G |
Col13a1 |
collagen type XIII alpha 1 chain |
multiple interactions |
ISO |
[tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in decreased expression of COL13A1 mRNA |
CTD |
PMID:33367866 |
|
NCBI chr20:29,783,965...29,924,116
Ensembl chr20:29,783,965...29,924,032
|
|
G |
Col14a1 |
collagen type XIV alpha 1 chain |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of COL14A1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 7:86,722,093...86,937,215
Ensembl chr 7:86,722,094...86,937,214
|
|
G |
Col1a2 |
collagen type I alpha 2 chain |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of COL1A2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 4:32,563,938...32,598,868
Ensembl chr 4:32,563,381...32,598,867
|
|
G |
Col24a1 |
collagen type XXIV alpha 1 chain |
multiple interactions |
ISO |
[tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in decreased expression of COL24A1 mRNA |
CTD |
PMID:33367866 |
|
NCBI chr 2:234,212,256...234,469,445
Ensembl chr 2:234,212,324...234,469,441
|
|
G |
Col4a1 |
collagen type IV alpha 1 chain |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of COL4A1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr16:78,183,533...78,294,412
Ensembl chr16:78,183,533...78,294,412
|
|
G |
Col5a1 |
collagen type V alpha 1 chain |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of COL5A1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 3:11,208,429...11,356,715
Ensembl chr 3:11,208,512...11,354,588
|
|
G |
Col5a2 |
collagen type V alpha 2 chain |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of COL5A2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 9:47,448,736...47,598,396
Ensembl chr 9:47,448,736...47,598,154
|
|
G |
Col6a3 |
collagen type VI alpha 3 chain |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of COL6A3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 9:91,361,578...91,439,434
Ensembl chr 9:91,361,583...91,439,471
|
|
G |
Colec11 |
collectin sub-family member 11 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of COLEC11 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 6:45,223,974...45,256,640
Ensembl chr 6:45,223,980...45,271,145
|
|
G |
Copz2 |
COPI coat complex subunit zeta 2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of COPZ2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr10:81,832,441...81,845,514
Ensembl chr10:81,832,418...81,845,514
|
|
G |
Corin |
corin, serine peptidase |
decreases expression |
ISO |
triphenyl phosphate results in decreased expression of CORIN mRNA |
CTD |
PMID:28934090 |
|
NCBI chr14:35,680,601...35,910,703
Ensembl chr14:35,681,304...35,909,503
|
|
G |
Coro1c |
coronin 1C |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CORO1C mRNA |
CTD |
PMID:30589522 |
|
NCBI chr12:42,712,960...42,785,179
Ensembl chr12:42,712,991...42,785,179
|
|
G |
Coro6 |
coronin 6 |
affects expression |
EXP |
triphenyl phosphate affects the expression of CORO6 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr10:62,311,552...62,319,659
Ensembl chr10:62,311,660...62,319,659
|
|
G |
Cotl1 |
coactosin-like F-actin binding protein 1 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of COTL1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr19:47,871,689...47,906,010
Ensembl chr19:47,871,694...47,911,689
|
|
G |
Cpne3 |
copine 3 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CPNE3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 5:33,014,658...33,064,004
Ensembl chr 5:33,016,307...33,063,934
|
|
G |
Cpne8 |
copine 8 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CPNE8 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 7:121,615,293...121,789,507
Ensembl chr 7:121,615,294...121,790,377
|
|
G |
Cpped1 |
calcineurin-like phosphoesterase domain containing 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CPPED1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr10:3,701,522...3,821,050
Ensembl chr10:3,701,459...3,821,054
|
|
G |
Cpsf6 |
cleavage and polyadenylation specific factor 6 |
affects expression |
EXP |
triphenyl phosphate affects the expression of CPSF6 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 7:52,956,589...53,001,783
Ensembl chr 7:52,956,589...52,988,122
|
|
G |
Cpt1a |
carnitine palmitoyltransferase 1A |
decreases expression affects expression |
ISO EXP |
triphenyl phosphate results in decreased expression of CPT1A mRNA triphenyl phosphate affects the expression of CPT1A mRNA |
CTD |
PMID:30589522 PMID:30966736 |
|
NCBI chr 1:200,564,634...200,627,059
Ensembl chr 1:200,565,613...200,627,055
|
|
G |
Cpt1b |
carnitine palmitoyltransferase 1B |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CPT1B mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 7:120,491,354...120,500,833
Ensembl chr 7:120,491,354...120,500,404
|
|
G |
Cpt2 |
carnitine palmitoyltransferase 2 |
increases expression |
ISO |
triphenyl phosphate results in increased expression of CPT2 mRNA |
CTD |
PMID:30966736 |
|
NCBI chr 5:122,664,677...122,682,126
Ensembl chr 5:122,664,677...122,682,095
|
|
G |
Cptp |
ceramide-1-phosphate transfer protein |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CPTP mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 5:166,474,947...166,479,103
Ensembl chr 5:166,474,966...166,479,017
|
|
G |
Crat |
carnitine O-acetyltransferase |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CRAT mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 3:13,675,684...13,689,282
Ensembl chr 3:13,675,684...13,689,255
|
|
G |
Crb3 |
crumbs cell polarity complex component 3 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CRB3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 9:1,898,531...1,903,860
Ensembl chr 9:1,896,623...1,903,859
|
|
G |
Creg1 |
cellular repressor of E1A-stimulated genes 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CREG1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr13:78,019,814...78,032,310
Ensembl chr13:78,019,843...78,032,308
|
|
G |
Crem |
cAMP responsive element modulator |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CREM mRNA |
CTD |
PMID:30589522 |
|
NCBI chr17:54,238,889...54,305,989
Ensembl chr17:54,239,030...54,305,989
|
|
G |
Crim1 |
cysteine rich transmembrane BMP regulator 1 |
affects expression |
EXP |
triphenyl phosphate affects the expression of CRIM1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 6:16,695,864...16,870,264
Ensembl chr 6:16,697,829...16,870,259
|
|
G |
Crip2 |
cysteine-rich protein 2 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CRIP2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 6:132,221,120...132,226,066
Ensembl chr 6:132,221,082...132,226,065
|
|
G |
Crot |
carnitine O-octanoyltransferase |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CROT mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 4:25,068,270...25,133,111
Ensembl chr 4:25,080,587...25,133,109
|
|
G |
Crppa |
CDP-L-ribitol pyrophosphorylase A |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ISPD mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 6:53,120,264...53,397,030
Ensembl chr 6:53,121,438...53,397,028
|
|
G |
Cry1 |
cryptochrome circadian regulator 1 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CRY1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 7:18,529,823...18,594,092
Ensembl chr 7:18,529,823...18,594,091
|
|
G |
Cry2 |
cryptochrome circadian regulator 2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CRY2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 3:78,374,995...78,405,001
Ensembl chr 3:78,374,995...78,404,965
|
|
G |
Crybg3 |
crystallin beta-gamma domain containing 3 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CRYBG3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr11:40,749,198...40,861,753
Ensembl chr11:40,749,214...40,861,752
|
|
G |
Cryl1 |
crystallin, lambda 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CRYL1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr15:31,427,011...31,545,997
Ensembl chr15:31,427,054...31,545,997
|
|
G |
Crym |
crystallin, mu |
affects expression |
EXP |
triphenyl phosphate affects the expression of CRYM mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:174,560,423...174,575,660
Ensembl chr 1:174,560,416...174,575,633
|
|
G |
Csf1r |
colony stimulating factor 1 receptor |
affects expression multiple interactions |
EXP ISO |
triphenyl phosphate affects the expression of CSF1R mRNA [tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in decreased expression of CSF1R mRNA |
CTD |
PMID:30589522 PMID:33367866 |
|
NCBI chr18:54,546,673...54,590,418
Ensembl chr18:54,546,659...54,590,415
|
|
G |
Csnk1d |
casein kinase 1, delta |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CSNK1D mRNA |
CTD |
PMID:30589522 |
|
NCBI chr10:106,221,992...106,256,620
Ensembl chr10:106,221,992...106,256,614
|
|
G |
Cspg5 |
chondroitin sulfate proteoglycan 5 |
increases expression |
ISO |
triphenyl phosphate results in increased expression of CSPG5 mRNA |
CTD |
PMID:35752650 |
|
NCBI chr 8:110,220,653...110,234,750
Ensembl chr 8:110,220,653...110,234,758
|
|
G |
Csrnp1 |
cysteine and serine rich nuclear protein 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CSRNP1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 8:119,704,712...119,717,767
Ensembl chr 8:119,704,713...119,718,183
|
|
G |
Csrp1 |
cysteine and glycine-rich protein 1 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CSRP1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr13:47,158,171...47,179,388
Ensembl chr13:47,167,789...47,179,384
|
|
G |
Ctf1 |
cardiotrophin 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CTF1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:182,328,035...182,336,346
Ensembl chr 1:182,328,090...182,333,335
|
|
G |
Cth |
cystathionine gamma-lyase |
decreases expression multiple interactions |
EXP ISO |
triphenyl phosphate results in decreased expression of CTH mRNA [tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in increased expression of CTH mRNA |
CTD |
PMID:30589522 PMID:33367866 |
|
NCBI chr 2:246,975,888...247,002,234
Ensembl chr 2:246,975,894...247,002,234
|
|
G |
Ctla4 |
cytotoxic T-lymphocyte-associated protein 4 |
decreases expression |
ISO |
triphenyl phosphate results in decreased expression of CTLA4 mRNA |
CTD |
PMID:35752650 |
|
NCBI chr 9:62,318,874...62,325,978
Ensembl chr 9:62,319,312...62,324,963
|
|
G |
Ctse |
cathepsin E |
affects expression |
EXP |
triphenyl phosphate affects the expression of CTSE mRNA |
CTD |
PMID:30589522 |
|
NCBI chr13:43,091,954...43,114,509
Ensembl chr13:43,092,128...43,114,502
|
|
G |
Cux2 |
cut-like homeobox 2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CUX2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr12:34,507,723...34,707,581
Ensembl chr12:34,520,959...34,705,806
|
|
G |
Cxadr |
CXADR, Ig-like cell adhesion molecule |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CXADR mRNA |
CTD |
PMID:30589522 |
|
NCBI chr11:16,982,752...17,030,078
Ensembl chr11:16,982,860...17,030,046
|
|
G |
Cxcl11 |
C-X-C motif chemokine ligand 11 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CXCL11 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr14:15,689,432...15,692,207
Ensembl chr14:15,689,424...15,692,271
|
|
G |
Cxcr4 |
C-X-C motif chemokine receptor 4 |
affects expression |
EXP |
triphenyl phosphate affects the expression of CXCR4 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
|
|
G |
Cyba |
cytochrome b-245 alpha chain |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CYBA mRNA |
CTD |
PMID:30589522 |
|
NCBI chr19:50,487,598...50,495,669
Ensembl chr19:50,487,597...50,495,721
|
|
G |
Cybb |
cytochrome b-245 beta chain |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CYBB mRNA |
CTD |
PMID:30589522 |
|
NCBI chr X:13,360,583...13,392,517
Ensembl chr X:13,359,430...13,392,586
|
|
G |
Cyfip2 |
cytoplasmic FMR1 interacting protein 2 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CYFIP2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr10:30,621,318...30,741,113
Ensembl chr10:30,621,318...30,741,113
|
|
G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
increases expression decreases expression |
ISO |
triphenyl phosphate results in increased expression of CYP11A1 mRNA triphenyl phosphate results in decreased expression of CYP11A1 mRNA |
CTD |
PMID:22446829 PMID:26049154 PMID:26183808 |
|
NCBI chr 8:58,422,807...58,434,342
Ensembl chr 8:58,404,669...58,434,338
|
|
G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
decreases expression multiple interactions |
ISO |
triphenyl phosphate results in decreased expression of CYP17A1 mRNA triphenyl phosphate inhibits the reaction [CGB3 protein results in increased expression of CYP17A1 mRNA] |
CTD |
PMID:26049154 PMID:26183808 |
|
NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
decreases expression increases expression |
EXP |
triphenyl phosphate results in decreased expression of CYP1A1 protein triphenyl phosphate results in increased expression of CYP1A1 mRNA |
CTD |
PMID:30589522 PMID:30974155 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CYP1A2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp26b1 |
cytochrome P450, family 26, subfamily b, polypeptide 1 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CYP26B1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 4:117,041,808...117,058,628
Ensembl chr 4:117,041,808...117,058,628
|
|
G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
multiple interactions increases expression |
ISO EXP |
[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of CYP2B10 mRNA; [tris(1,3-dichloro-2-propyl)phosphate co-treated with Tritolyl Phosphates co-treated with triphenyl phosphate] results in increased expression of CYP2B10 mRNA triphenyl phosphate results in increased expression of CYP2B1 mRNA |
CTD |
PMID:29112739 PMID:30589522 PMID:32360330 |
|
NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052
|
|
G |
Cyp2f4 |
cytochrome P450, family 2, subfamily f, polypeptide 4 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CYP2F4 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:82,416,108...82,429,897
Ensembl chr 1:82,416,130...82,429,896
|
|
G |
Cyp2j4 |
cytochrome P450, family 2, subfamily j, polypeptide 4 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CYP2J4 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 5:111,179,981...111,207,490
Ensembl chr 5:111,178,703...111,244,794
|
|
G |
Cyp2t1 |
cytochrome P450, family 2, subfamily t, polypeptide 1 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CYP2T1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:82,446,321...82,451,564
Ensembl chr 1:82,446,921...82,451,563
|
|
G |
Cyp3a23-3a1 |
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CYP3A23-3A1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr12:9,256,159...9,285,020
Ensembl chr12:9,254,475...9,285,030
|
|
G |
Cyp4a1 |
cytochrome P450, family 4, subfamily a, polypeptide 1 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CYP4A1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 5:129,123,323...129,137,464
Ensembl chr 5:129,123,336...129,137,464
|
|
G |
Cyp4a2 |
cytochrome P450, family 4, subfamily a, polypeptide 2 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CYP4A2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 5:128,922,355...128,934,188
Ensembl chr 5:128,923,615...128,934,165
|
|
G |
Cyp4a3 |
cytochrome P450, family 4, subfamily a, polypeptide 3 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of CYP4A3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 5:129,097,571...129,115,488
Ensembl chr 5:129,097,926...129,115,463
|
|
G |
Cyp4a8 |
cytochrome P450, family 4, subfamily a, polypeptide 8 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of CYP4A8 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 5:128,702,130...128,733,476
Ensembl chr 5:128,702,131...128,733,476
|
|
G |
Cyp51 |
cytochrome P450, family 51 |
affects expression |
EXP |
triphenyl phosphate affects the expression of CYP51 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 4:30,036,956...30,055,410
Ensembl chr 4:30,036,865...30,055,410
|
|
G |
Cyp7a1 |
cytochrome P450 family 7 subfamily A member 1 |
increases expression affects expression |
EXP ISO |
triphenyl phosphate results in increased expression of CYP7A1 mRNA triphenyl phosphate affects the expression of CYP7A1 mRNA |
CTD |
PMID:30589522 PMID:36563926 |
|
NCBI chr 5:19,376,979...19,386,676
Ensembl chr 5:19,376,974...19,386,688
|
|
G |
Dab1 |
DAB adaptor protein 1 |
affects expression |
EXP |
triphenyl phosphate affects the expression of DAB1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 5:118,392,953...119,513,625
Ensembl chr 5:119,140,533...119,510,552
|
|
G |
Dact2 |
dishevelled-binding antagonist of beta-catenin 2 |
affects expression |
EXP |
triphenyl phosphate affects the expression of DACT2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:55,181,023...55,191,026
Ensembl chr 1:55,181,024...55,191,096
|
|
G |
Dap |
death-associated protein |
increases expression |
EXP |
triphenyl phosphate results in increased expression of DAP mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:82,199,206...82,251,771
Ensembl chr 2:82,199,280...82,251,752
|
|
G |
Dapk1 |
death associated protein kinase 1 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of DAPK1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr17:3,930,223...4,090,991
Ensembl chr17:3,930,213...4,090,991
|
|
G |
Dbp |
D-box binding PAR bZIP transcription factor |
increases expression |
EXP |
triphenyl phosphate results in increased expression of DBP mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:96,175,796...96,180,745
Ensembl chr 1:96,175,440...96,180,745
|
|
G |
Ddah1 |
dimethylarginine dimethylaminohydrolase 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of DDAH1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:234,667,499...234,800,322
Ensembl chr 2:234,667,491...234,799,339
|
|
G |
Ddc |
dopa decarboxylase |
multiple interactions |
EXP |
[triphenyl phosphate co-treated with Flame Retardants] results in decreased expression of DDC mRNA |
CTD |
PMID:32243540 |
|
NCBI chr14:86,378,685...86,469,189
Ensembl chr14:86,378,685...86,469,208
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
multiple interactions |
ISO |
[tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in increased expression of DDIT3 mRNA |
CTD |
PMID:33367866 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Ddit4 |
DNA-damage-inducible transcript 4 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of DDIT4 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr20:27,891,989...27,894,088
Ensembl chr20:27,891,998...27,894,105
|
|
G |
Ddit4l |
DNA-damage-inducible transcript 4-like |
affects expression |
EXP |
triphenyl phosphate affects the expression of DDIT4L mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:226,128,273...226,131,044
Ensembl chr 2:226,128,276...226,131,375
|
|
G |
Ddx21 |
DExD-box helicase 21 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of DDX21 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr20:30,534,319...30,554,513
Ensembl chr20:30,534,319...30,554,543
|
|
G |
Ddx6 |
DEAD-box helicase 6 |
affects expression |
EXP |
triphenyl phosphate affects the expression of DDX6 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 8:44,931,127...44,967,773
Ensembl chr 8:44,931,974...44,964,405
|
|
G |
Dedd |
death effector domain-containing |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of DEDD mRNA |
CTD |
PMID:30589522 |
|
NCBI chr13:83,755,874...83,769,982
Ensembl chr13:83,756,108...83,769,332
|
|
G |
Dennd2a |
DENN domain containing 2A |
affects expression |
EXP |
triphenyl phosphate affects the expression of DENND2A mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 4:68,233,016...68,332,235
Ensembl chr 4:68,233,958...68,332,105
|
|
G |
Depp1 |
DEPP autophagy regulator 1 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of DEPP1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 4:149,910,794...149,913,013
Ensembl chr 4:149,910,779...149,914,542
|
|
G |
Desi2 |
desumoylating isopeptidase 2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of DESI2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr13:89,961,767...90,011,255
Ensembl chr13:89,961,934...90,016,416
|
|
G |
Dgat2 |
diacylglycerol O-acyltransferase 2 |
increases expression multiple interactions |
ISO |
triphenyl phosphate results in increased expression of DGAT2 mRNA [tris(1,3-dichloro-2-propyl)phosphate co-treated with Tritolyl Phosphates co-treated with triphenyl phosphate] affects the expression of DGAT2 mRNA |
CTD |
PMID:30966736 PMID:32360330 |
|
NCBI chr 1:153,454,078...153,484,432
Ensembl chr 1:153,454,080...153,484,428
|
|
G |
Dgkd |
diacylglycerol kinase, delta |
increases expression |
EXP |
triphenyl phosphate results in increased expression of DGKD mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 9:88,516,686...88,607,349
Ensembl chr 9:88,516,715...88,607,345
|
|
G |
Dido1 |
death inducer-obliterator 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of DIDO1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 3:167,772,535...167,825,894
Ensembl chr 3:167,772,770...167,817,218
|
|
G |
Dipk1a |
divergent protein kinase domain 1A |
increases expression |
EXP |
triphenyl phosphate results in increased expression of FAM69A mRNA |
CTD |
PMID:30589522 |
|
NCBI chr14:1,772,412...1,843,508
Ensembl chr14:1,772,422...1,843,743
|
|
G |
Dipk2a |
divergent protein kinase domain 2A |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of DIPK2A mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 8:95,070,695...95,089,815
Ensembl chr 8:95,030,279...95,089,815
|
|
G |
Dlg3 |
discs large MAGUK scaffold protein 3 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of DLG3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr X:65,859,653...65,911,887
Ensembl chr X:65,860,172...65,910,322
|
|
G |
Dnajb6 |
DnaJ heat shock protein family (Hsp40) member B6 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of DNAJB6 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 4:5,452,683...5,556,679
Ensembl chr 4:5,452,683...5,556,659
|
|
G |
Dnph1 |
2'-deoxynucleoside 5'-phosphate N-hydrolase 1 |
increases expression |
ISO |
triphenyl phosphate results in increased expression of DNPH1 mRNA |
CTD |
PMID:35776891 |
|
NCBI chr 9:14,481,296...14,484,034
Ensembl chr 9:14,481,066...14,484,022
|
|
G |
Dsc2 |
desmocollin 2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of DSC2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr18:11,450,392...11,482,476
Ensembl chr18:11,450,390...11,482,392
|
|
G |
Dusp5 |
dual specificity phosphatase 5 |
increases expression |
ISO |
triphenyl phosphate results in increased expression of DUSP5 mRNA |
CTD |
PMID:35776891 |
|
NCBI chr 1:252,538,408...252,555,320
Ensembl chr 1:252,538,449...252,551,818
|
|
G |
Dut |
deoxyuridine triphosphatase |
increases expression |
EXP |
triphenyl phosphate results in increased expression of DUT mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 3:112,498,864...112,509,994
Ensembl chr 3:112,498,982...112,510,771
|
|
G |
Dym |
dymeclin |
increases expression |
EXP |
triphenyl phosphate results in increased expression of DYM mRNA |
CTD |
PMID:30589522 |
|
NCBI chr18:68,605,131...68,900,905
Ensembl chr18:68,605,185...68,900,903
|
|
G |
Echdc3 |
enoyl CoA hydratase domain containing 3 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ECHDC3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr17:72,070,697...72,093,519
Ensembl chr17:72,070,668...72,093,516
|
|
G |
Ecm1 |
extracellular matrix protein 1 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of ECM1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:183,287,491...183,292,729
Ensembl chr 2:183,287,322...183,292,671
|
|
G |
Edem2 |
ER degradation enhancing alpha-mannosidase like protein 2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of EDEM2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 3:144,201,604...144,227,423
Ensembl chr 3:144,201,605...144,227,485
|
|
G |
Eef2k |
eukaryotic elongation factor-2 kinase |
increases expression |
EXP |
triphenyl phosphate results in increased expression of EEF2K mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:175,393,119...175,454,452
Ensembl chr 1:175,393,154...175,455,164
|
|
G |
Eeig1 |
estrogen-induced osteoclastogenesis regulator 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of EEIG1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 3:15,823,147...15,854,651
Ensembl chr 3:15,823,144...15,854,643
|
|
G |
Efna1 |
ephrin A1 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of EFNA1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:174,681,676...174,690,306
Ensembl chr 2:174,681,682...174,690,866
|
|
G |
Egf |
epidermal growth factor |
increases expression |
ISO |
triphenyl phosphate results in increased expression of EGF mRNA |
CTD |
PMID:35776891 |
|
NCBI chr 2:218,219,408...218,302,370
Ensembl chr 2:218,219,415...218,302,064
|
|
G |
Egfr |
epidermal growth factor receptor |
decreases expression increases expression |
EXP ISO |
triphenyl phosphate results in decreased expression of EGFR mRNA triphenyl phosphate results in increased expression of EGFR mRNA |
CTD |
PMID:30589522 PMID:35776891 |
|
NCBI chr14:91,176,931...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Egln1 |
egl-9 family hypoxia-inducible factor 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of EGLN1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr19:52,867,914...52,907,169
Ensembl chr19:52,869,486...52,907,777
|
|
G |
Egln3 |
egl-9 family hypoxia-inducible factor 3 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of EGLN3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 6:71,650,297...71,675,766
Ensembl chr 6:71,650,297...71,675,766
|
|
G |
Egr1 |
early growth response 1 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of EGR1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr18:26,463,333...26,465,531
Ensembl chr18:26,462,981...26,466,766
|
|
G |
Eif1a |
eukaryotic translation initiation factor 1A |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of EIF1A mRNA |
CTD |
PMID:30589522 |
|
NCBI chr18:39,325,695...39,338,043
Ensembl chr18:39,325,202...39,338,696
|
|
G |
Eif4ebp3 |
eukaryotic translation initiation factor 4E binding protein 3 |
affects expression |
EXP |
triphenyl phosphate affects the expression of EIF4EBP3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr18:28,263,089...28,268,033
Ensembl chr18:28,162,311...28,268,024
|
|
G |
Elovl3 |
ELOVL fatty acid elongase 3 |
multiple interactions |
ISO |
[triphenyl phosphate co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ELOVL3 mRNA |
CTD |
PMID:34323617 |
|
NCBI chr 1:244,997,287...245,001,115
Ensembl chr 1:244,997,287...245,001,115
|
|
G |
Elovl6 |
ELOVL fatty acid elongase 6 |
affects expression |
EXP |
triphenyl phosphate affects the expression of ELOVL6 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:218,063,682...218,174,767
Ensembl chr 2:218,063,804...218,171,186
|
|
G |
Eml4 |
EMAP like 4 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of EML4 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 6:11,219,545...11,334,824
Ensembl chr 6:11,219,566...11,334,879
|
|
G |
Enc1 |
ectodermal-neural cortex 1 |
affects expression |
EXP |
triphenyl phosphate affects the expression of ENC1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:28,550,670...28,562,591
Ensembl chr 2:28,550,464...28,562,713
|
|
G |
Entr1 |
endosome associated trafficking regulator 1 |
affects expression |
EXP |
triphenyl phosphate affects the expression of ENTR1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 3:9,200,967...9,207,688
Ensembl chr 3:9,200,967...9,207,688
|
|
G |
Epb41l1 |
erythrocyte membrane protein band 4.1-like 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of EPB41L1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 3:144,929,195...145,052,723
Ensembl chr 3:144,984,640...145,052,721
|
|
G |
Epcam |
epithelial cell adhesion molecule |
increases expression |
EXP |
triphenyl phosphate results in increased expression of EPCAM mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 6:6,880,142...6,896,103
Ensembl chr 6:6,878,237...6,896,127
|
|
G |
Epha2 |
Eph receptor A2 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of EPHA2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 5:153,605,644...153,634,115
Ensembl chr 5:153,605,644...153,634,117
|
|
G |
Ephx1 |
epoxide hydrolase 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of EPHX1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr13:92,714,315...92,744,124
Ensembl chr13:92,714,315...92,790,235
|
|
G |
Eprs1 |
glutamyl-prolyl-tRNA synthetase 1 |
affects expression |
EXP |
triphenyl phosphate affects the expression of EPRS mRNA |
CTD |
PMID:30589522 |
|
NCBI chr13:96,901,548...96,971,966
Ensembl chr13:96,901,575...96,971,966
|
|
G |
Eps15 |
epidermal growth factor receptor pathway substrate 15 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of EPS15 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 5:124,045,865...124,146,221
Ensembl chr 5:124,045,926...124,146,221
|
|
G |
Ereg |
epiregulin |
increases expression |
ISO |
triphenyl phosphate results in increased expression of EREG mRNA |
CTD |
PMID:35776891 |
|
NCBI chr14:17,027,287...17,041,062
Ensembl chr14:17,027,287...17,041,062
|
|
G |
Erg28 |
ergosterol biosynthesis 28 homolog |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ERG28 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 6:105,474,112...105,483,078
Ensembl chr 6:105,474,113...105,483,078
|
|
G |
Eri2 |
ERI1 exoribonuclease family member 2 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of ERI2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:174,140,831...174,168,757
Ensembl chr 1:174,141,993...174,168,665
|
|
G |
Errfi1 |
ERBB receptor feedback inhibitor 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ERRFI1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 5:161,323,981...161,337,289
Ensembl chr 5:161,323,998...161,337,282
|
|
G |
Esr1 |
estrogen receptor 1 |
multiple interactions increases activity |
ISO |
triphenyl phosphate binds to and results in increased activity of ESR1 protein [tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in decreased expression of ESR1 mRNA; [tris(1,3-dichloro-2-propyl)phosphate co-treated with Tritolyl Phosphates co-treated with triphenyl phosphate] results in increased expression of ESR1 mRNA; ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in decreased expression of and results in decreased secretion of INS1 protein]; ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in decreased expression of and results in decreased secretion of LEP protein]; ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in decreased expression of CARTPT mRNA]; ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in decreased expression of CD36 mRNA]; ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in decreased expression of CYP4A10 mRNA]; ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in decreased expression of GHSR mRNA]; ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in decreased expression of NPY mRNA]; ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in decreased expression of NR0B2 mRNA]; ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of CACNA1G mRNA]; ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of CACNA1H mRNA]; ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of CACNA1I mRNA]; ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of GHSR mRNA]; ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of INSR mRNA]; ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of KCNQ2 mRNA]; ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of KCNQ3 mRNA]; ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of KCNQ5 mRNA]; ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of KISS1 mRNA]; ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of LEPR mRNA]; ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of TRPC5 mRNA]; ESR1 gene mutant form results in decreased susceptibility to [tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] triphenyl phosphate metabolite results in increased activity of ESR1 protein; triphenyl phosphate results in increased activity of ESR1 protein |
CTD |
PMID:23398518 PMID:24051214 PMID:24844797 PMID:26778350 PMID:28728110 PMID:29112739 PMID:32360330 PMID:33049310 More...
|
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Esr2 |
estrogen receptor 2 |
increases activity multiple interactions |
ISO |
triphenyl phosphate metabolite results in increased activity of ESR2 protein; triphenyl phosphate results in increased activity of ESR2 protein triphenyl phosphate metabolite inhibits the reaction [Estradiol results in increased activity of ESR2 protein] |
CTD |
PMID:26778350 |
|
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
|
|
G |
Etv6 |
ETS variant transcription factor 6 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of ETV6 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 4:166,849,031...167,085,211
Ensembl chr 4:166,847,686...167,084,992
|
|
G |
Evi2b |
ecotropic viral integration site 2B |
affects expression |
EXP |
triphenyl phosphate affects the expression of EVI2B mRNA |
CTD |
PMID:30589522 |
|
NCBI chr10:64,472,693...64,474,311
Ensembl chr10:64,471,505...64,481,560
|
|
G |
Exph5 |
exophilin 5 |
affects expression |
EXP |
triphenyl phosphate affects the expression of EXPH5 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 8:53,698,825...53,775,371
Ensembl chr 8:53,698,852...53,773,169
|
|
G |
F11r |
F11 receptor |
decreases expression |
ISO |
triphenyl phosphate results in decreased expression of F11R mRNA |
CTD |
PMID:35752650 |
|
NCBI chr13:83,873,797...83,897,388
Ensembl chr13:83,873,797...83,897,402
|
|
G |
Fabp4 |
fatty acid binding protein 4 |
multiple interactions increases expression |
ISO |
[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS1 protein co-treated with triphenyl phosphate] results in increased expression of FABP4 mRNA; [triphenyl phosphate co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FABP4 mRNA 2-chloro-5-nitrobenzanilide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with triphenyl phosphate analog] results in increased expression of FABP4 mRNA]; 2-chloro-5-nitrobenzanilide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with triphenyl phosphate] results in increased expression of FABP4 mRNA]; [1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with triphenyl phosphate analog] results in increased expression of FABP4 mRNA; [1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with triphenyl phosphate analog] results in increased expression of FABP4 protein; [1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with triphenyl phosphate] results in increased expression of FABP4 mRNA; [1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with triphenyl phosphate] results in increased expression of FABP4 protein triphenyl phosphate results in increased expression of FABP4 mRNA; triphenyl phosphate results in increased expression of FABP4 protein |
CTD |
PMID:25062436 PMID:28437481 PMID:28934090 PMID:34323617 |
|
NCBI chr 2:91,580,858...91,585,578
Ensembl chr 2:91,580,885...91,585,578
|
|
G |
Fabp5 |
fatty acid binding protein 5 |
increases expression decreases expression |
ISO EXP |
triphenyl phosphate results in increased expression of FABP5 mRNA triphenyl phosphate results in decreased expression of FABP5 mRNA |
CTD |
PMID:28934090 PMID:30589522 |
|
NCBI chr 2:91,765,056...91,768,716
Ensembl chr 2:91,765,056...91,853,773
|
|
G |
Fabp7 |
fatty acid binding protein 7 |
affects expression |
EXP |
triphenyl phosphate affects the expression of FABP7 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr20:37,123,193...37,126,725
Ensembl chr20:37,123,193...37,126,880
|
|
G |
Fam117a |
family with sequence similarity 117, member A |
increases expression |
EXP |
triphenyl phosphate results in increased expression of FAM117A mRNA |
CTD |
PMID:30589522 |
|
NCBI chr10:80,281,408...80,325,343
Ensembl chr10:80,281,408...80,325,343
|
|
G |
Fam117b |
family with sequence similarity 117, member B |
increases expression |
EXP |
triphenyl phosphate results in increased expression of FAM117B mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 9:61,340,291...61,418,531
Ensembl chr 9:61,340,249...61,408,483
|
|
G |
FAM120C |
family with sequence similarity 120C |
increases expression |
EXP |
triphenyl phosphate results in increased expression of FAM120C mRNA |
CTD |
PMID:30589522 |
|
NCBI chr X:20,324,046...20,477,831
Ensembl chr X:20,323,381...20,477,275
|
|
G |
Fam168a |
family with sequence similarity 168, member A |
affects expression |
EXP |
triphenyl phosphate affects the expression of FAM168A mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:155,057,352...155,203,439
Ensembl chr 1:155,057,352...155,201,220
|
|
G |
Fam174c |
family with sequence similarity 174 member C |
increases expression |
EXP |
triphenyl phosphate results in increased expression of FAM174C mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 7:9,531,995...9,533,705
|
|
G |
Fam20c |
FAM20C, golgi associated secretory pathway kinase |
increases expression |
EXP |
triphenyl phosphate results in increased expression of FAM20C mRNA |
CTD |
PMID:30589522 |
|
NCBI chr12:15,826,864...15,885,423
Ensembl chr12:15,826,871...15,884,543
|
|
G |
Fam76a |
family with sequence similarity 76, member A |
increases expression |
EXP |
triphenyl phosphate results in increased expression of FAM76A mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 5:145,107,491...145,135,734
Ensembl chr 5:145,107,491...145,135,574
|
|
G |
Fam89a |
family with sequence similarity 89, member A |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of FAM89A mRNA |
CTD |
PMID:30589522 |
|
NCBI chr19:52,710,003...52,722,591
Ensembl chr19:52,710,019...52,722,631
|
|
G |
Fas |
Fas cell surface death receptor |
increases expression |
EXP |
triphenyl phosphate results in increased expression of FAS mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Fasn |
fatty acid synthase |
increases expression multiple interactions affects expression |
ISO EXP |
triphenyl phosphate results in increased expression of FASN mRNA [tris(1,3-dichloro-2-propyl)phosphate co-treated with Tritolyl Phosphates co-treated with triphenyl phosphate] results in decreased expression of FASN mRNA triphenyl phosphate affects the expression of FASN mRNA |
CTD |
PMID:28163246 PMID:28934090 PMID:30589522 PMID:32360330 |
|
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
|
|
G |
Fbn1 |
fibrillin 1 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of FBN1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 3:112,554,257...112,750,835
Ensembl chr 3:112,554,925...112,750,889
|
|
G |
Fbxl22 |
F-box and leucine-rich repeat protein 22 |
decreases expression |
ISO |
triphenyl phosphate results in decreased expression of FBXL22 mRNA |
CTD |
PMID:28934090 |
|
NCBI chr 8:67,069,998...67,076,685
Ensembl chr 8:67,069,998...67,076,685
|
|
G |
Fbxo30 |
F-box protein 30 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of FBXO30 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:5,655,341...5,671,558
Ensembl chr 1:5,655,339...5,672,441
|
|
G |
Fbxo6 |
F-box protein 6 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of FBXO6 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 5:158,576,729...158,582,520
Ensembl chr 5:158,576,759...158,582,525
|
|
G |
Fcer1g |
Fc epsilon receptor Ig |
affects expression |
EXP |
triphenyl phosphate affects the expression of FCER1G mRNA |
CTD |
PMID:30589522 |
|
NCBI chr13:83,649,447...83,654,215
Ensembl chr13:83,649,449...83,671,443
|
|
G |
Fcnb |
ficolin B |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of FCN1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 3:11,393,771...11,402,198
Ensembl chr 3:11,393,739...11,402,151
|
|
G |
Fdft1 |
farnesyl diphosphate farnesyl transferase 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of FDFT1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr15:37,412,143...37,440,198
Ensembl chr15:37,412,146...37,440,287
|
|
G |
Fgf19 |
fibroblast growth factor 19 |
decreases expression |
ISO |
triphenyl phosphate results in decreased expression of FGF15 mRNA |
CTD |
PMID:36563926 |
|
NCBI chr 1:200,056,656...200,059,944
Ensembl chr 1:200,056,644...200,060,287
|
|
G |
Fgf21 |
fibroblast growth factor 21 |
multiple interactions |
ISO |
[tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in increased expression of FGF21 mRNA |
CTD |
PMID:33367866 |
|
NCBI chr 1:96,083,495...96,084,738
Ensembl chr 1:96,083,441...96,090,454
|
|
G |
Fgl2 |
fibrinogen-like 2 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of FGL2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 4:13,710,566...13,716,207
Ensembl chr 4:13,710,575...13,716,207
|
|
G |
Fkbp11 |
FKBP prolyl isomerase 11 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of FKBP11 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 7:129,871,870...129,877,760
Ensembl chr 7:129,871,870...129,875,303
|
|
G |
Fktn |
fukutin |
increases expression |
EXP |
triphenyl phosphate results in increased expression of FKTN mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 5:68,339,803...68,396,412
Ensembl chr 5:68,340,028...68,396,409
|
|
G |
Flcn |
folliculin |
multiple interactions |
ISO |
[tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in increased expression of FLCN mRNA |
CTD |
PMID:33367866 |
|
NCBI chr10:44,588,621...44,607,808
Ensembl chr10:44,588,624...44,607,769
|
|
G |
Flvcr2 |
FLVCR heme transporter 2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of FLVCR2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 6:105,408,355...105,472,355
Ensembl chr 6:105,408,339...105,472,353
|
|
G |
Fmo1 |
flavin containing dimethylaniline monoxygenase 1 |
affects expression |
EXP |
triphenyl phosphate affects the expression of FMO1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr13:75,182,184...75,214,439
Ensembl chr13:75,182,176...75,214,647
|
|
G |
Fn3krp |
fructosamine-3-kinase-related protein |
increases expression |
EXP |
triphenyl phosphate results in increased expression of FN3KRP mRNA |
CTD |
PMID:30589522 |
|
NCBI chr10:106,688,404...106,696,290
Ensembl chr10:106,688,439...106,697,134
|
|
G |
Fndc5 |
fibronectin type III domain containing 5 |
increases expression |
ISO |
triphenyl phosphate results in increased expression of FNDC5 mRNA |
CTD |
PMID:28934090 |
|
NCBI chr 5:141,481,593...141,491,257
Ensembl chr 5:141,481,590...141,490,731
|
|
G |
Fnip2 |
folliculin interacting protein 2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of FNIP2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:164,596,557...164,708,147
Ensembl chr 2:164,598,906...164,707,901
|
|
G |
Foxa1 |
forkhead box A1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of FOXA1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 6:75,099,907...75,136,534
Ensembl chr 6:75,103,503...75,136,188
|
|
G |
Foxa2 |
forkhead box A2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of FOXA2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 3:135,470,123...135,474,326
Ensembl chr 3:135,470,131...135,474,326
|
|
G |
Foxa3 |
forkhead box A3 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of FOXA3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:78,662,067...78,672,321
Ensembl chr 1:78,662,431...78,672,155
|
|
G |
Foxk2 |
forkhead box K2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of FOXK2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr10:106,542,643...106,592,569
Ensembl chr10:106,542,566...106,592,563
|
|
G |
Foxn3 |
forkhead box N3 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of FOXN3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 6:118,462,018...118,842,442
Ensembl chr 6:118,466,025...118,842,401
|
|
G |
Foxo1 |
forkhead box O1 |
multiple interactions |
ISO |
[tris(1,3-dichloro-2-propyl)phosphate co-treated with Tritolyl Phosphates co-treated with triphenyl phosphate] results in increased expression of FOXO1 mRNA |
CTD |
PMID:32360330 |
|
NCBI chr 2:136,312,168...136,390,603
Ensembl chr 2:136,312,168...136,387,790
|
|
G |
Foxo3 |
forkhead box O3 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of FOXO3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr20:45,669,708...45,764,606
Ensembl chr20:45,672,995...45,764,561
|
|
G |
Foxp2 |
forkhead box P2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of FOXP2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 4:43,133,827...43,712,442
Ensembl chr 4:43,133,912...43,711,683
|
|
G |
Frat2 |
FRAT regulator of WNT signaling pathway 2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of FRAT2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:240,654,120...240,656,685
Ensembl chr 1:240,654,137...240,656,517
|
|
G |
Frk |
fyn-related Src family tyrosine kinase |
increases expression |
EXP |
triphenyl phosphate results in increased expression of FRK mRNA |
CTD |
PMID:30589522 |
|
NCBI chr20:38,265,416...38,371,038
Ensembl chr20:38,265,280...38,371,114
|
|
G |
Frs3 |
fibroblast growth factor receptor substrate 3 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of FRS3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 9:13,288,559...13,297,285
Ensembl chr 9:13,288,667...13,295,382
|
|
G |
Fsd1l |
fibronectin type III and SPRY domain containing 1-like |
increases expression |
EXP |
triphenyl phosphate results in increased expression of FSD1L mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 5:68,258,877...68,334,931
Ensembl chr 5:68,258,932...68,334,928
|
|
G |
Fundc2 |
FUN14 domain containing 2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of FUNDC2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr18:128,473...138,232
Ensembl chr18:132,248...138,345
|
|
G |
Fus |
Fus RNA binding protein |
affects expression |
EXP |
triphenyl phosphate affects the expression of FUS mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:182,576,479...182,590,417
Ensembl chr 1:182,576,545...182,590,414
|
|
G |
G6pc1 |
glucose-6-phosphatase catalytic subunit 1 |
decreases expression multiple interactions |
EXP ISO |
triphenyl phosphate results in decreased expression of G6PC1 mRNA [tris(1,3-dichloro-2-propyl)phosphate co-treated with Tritolyl Phosphates co-treated with triphenyl phosphate] results in decreased expression of G6PC mRNA |
CTD |
PMID:30589522 PMID:32360330 |
|
NCBI chr10:86,307,400...86,318,766
Ensembl chr10:86,257,668...86,333,804
|
|
G |
Gabra1 |
gamma-aminobutyric acid type A receptor subunit alpha 1 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of GABRA1 mRNA |
CTD |
PMID:33078273 |
|
NCBI chr10:26,595,151...26,650,611
Ensembl chr10:26,595,160...26,650,864
|
|
G |
Gad1 |
glutamate decarboxylase 1 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of GAD1 mRNA |
CTD |
PMID:33078273 |
|
NCBI chr 3:55,369,704...55,410,335
Ensembl chr 3:55,369,704...55,410,333
|
|
G |
Gad2 |
glutamate decarboxylase 2 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of GAD2 mRNA |
CTD |
PMID:33078273 |
|
NCBI chr17:84,763,630...84,826,155
Ensembl chr17:84,763,628...84,826,155
|
|
G |
Gar1 |
GAR1 ribonucleoprotein |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of GAR1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:218,375,231...218,382,509
Ensembl chr 2:218,375,353...218,382,524
|
|
G |
Gas5 |
growth arrest specific 5 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of GAS5 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr13:73,303,611...73,306,932
|
|
G |
Gckr |
glucokinase regulator |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of GCKR mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 6:25,044,592...25,075,834
Ensembl chr 6:25,045,100...25,075,654
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
affects expression |
EXP |
triphenyl phosphate affects the expression of GCLC mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
increases expression |
EXP |
triphenyl phosphate results in increased expression of GCLM mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
|
|
G |
Gcnt2 |
glucosaminyl (N-acetyl) transferase 2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of GCNT2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr17:23,796,859...23,901,625 NCBI chr17:23,866,602...23,868,691
Ensembl chr17:23,796,859...23,901,611
|
|
G |
Gda |
guanine deaminase |
affects expression |
EXP |
triphenyl phosphate affects the expression of GDA mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:218,903,045...218,982,360
Ensembl chr 1:218,906,815...218,982,416
|
|
G |
Gdf15 |
growth differentiation factor 15 |
multiple interactions |
ISO |
[tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in increased expression of GDF15 mRNA |
CTD |
PMID:33367866 |
|
NCBI chr16:18,805,312...18,807,893
Ensembl chr16:18,805,239...18,808,055
|
|
G |
Gdpd1 |
glycerophosphodiester phosphodiesterase domain containing 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of GDPD1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr10:71,840,497...71,883,936
Ensembl chr10:71,840,497...71,883,850
|
|
G |
Gfap |
glial fibrillary acidic protein |
affects expression |
EXP |
triphenyl phosphate affects the expression of GFAP mRNA |
CTD |
PMID:33078273 |
|
NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
|
|
G |
Ggt1 |
gamma-glutamyltransferase 1 |
affects expression |
EXP |
triphenyl phosphate affects the expression of GGT1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr20:13,074,695...13,104,095
Ensembl chr20:13,074,700...13,108,442
|
|
G |
Ghrl |
ghrelin and obestatin prepropeptide |
multiple interactions |
ISO |
[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of and results in increased secretion of GHRL protein |
CTD |
PMID:29112739 |
|
NCBI chr 4:146,865,712...146,869,621
Ensembl chr 4:146,865,712...146,869,621
|
|
G |
Ghsr |
growth hormone secretagogue receptor |
multiple interactions |
ISO |
[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in decreased expression of GHSR mRNA; [tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of GHSR mRNA; ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in decreased expression of GHSR mRNA]; ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of GHSR mRNA] |
CTD |
PMID:29112739 |
|
NCBI chr 2:110,268,489...110,271,865
Ensembl chr 2:110,268,489...110,271,865
|
|
G |
Glul |
glutamate-ammonia ligase |
affects expression decreases expression |
EXP |
triphenyl phosphate affects the expression of GLUL mRNA triphenyl phosphate results in decreased expression of GLUL mRNA |
CTD |
PMID:30589522 |
|
NCBI chr13:65,969,064...66,035,121
Ensembl chr13:66,025,630...66,035,108
|
|
G |
Gmppb |
GDP-mannose pyrophosphorylase B |
increases expression |
EXP |
triphenyl phosphate results in increased expression of GMPPB mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 8:108,737,429...108,767,286
Ensembl chr 8:108,693,060...108,767,286
|
|
G |
Gna12 |
G protein subunit alpha 12 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of GNA12 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr12:13,805,580...13,886,255
Ensembl chr12:13,805,698...13,886,255
|
|
G |
Gna14 |
G protein subunit alpha 14 |
affects expression |
EXP |
triphenyl phosphate affects the expression of GNA14 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:213,714,993...213,900,083
Ensembl chr 1:213,716,020...213,897,423
|
|
G |
Gnmt |
glycine N-methyltransferase |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of GNMT mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 9:14,254,675...14,258,028
Ensembl chr 9:14,254,675...14,258,434
|
|
G |
Got1 |
glutamic-oxaloacetic transaminase 1 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of GOT1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:242,357,293...242,381,535
Ensembl chr 1:242,357,306...242,380,633
|
|
G |
Gpbar1 |
G protein-coupled bile acid receptor 1 |
increases expression |
ISO |
triphenyl phosphate results in increased expression of GPBAR1 mRNA |
CTD |
PMID:28934090 |
|
NCBI chr 9:75,862,151...75,863,140
Ensembl chr 9:75,860,677...75,863,168
|
|
G |
Gpd1l1 |
glycerol-3-phosphate dehydrogenase 1 like 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of GPD1L mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 8:114,591,103...114,620,771
Ensembl chr 8:114,588,487...114,620,723
|
|
G |
Gpi |
glucose-6-phosphate isomerase |
increases expression |
EXP |
triphenyl phosphate results in increased expression of GPI mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:86,828,211...86,856,077
Ensembl chr 1:86,828,216...86,856,086
|
|
G |
Gpr146 |
G protein-coupled receptor 146 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of GPR146 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr12:15,251,936...15,267,217
Ensembl chr12:15,251,813...15,267,206
|
|
G |
Gpr180 |
G protein-coupled receptor 180 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of GPR180 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr15:95,195,782...95,224,955
Ensembl chr15:95,199,777...95,228,373
|
|
G |
Gpr19 |
G protein-coupled receptor 19 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of GPR19 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 4:167,710,944...167,739,232
Ensembl chr 4:167,710,666...167,741,036
|
|
G |
Gpr68 |
G protein-coupled receptor 68 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of GPR68 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 6:120,135,620...120,166,089
Ensembl chr 6:120,135,436...120,166,089
|
|
G |
Gpsm2 |
G-protein signaling modulator 2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of GPSM2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:196,327,149...196,375,322
Ensembl chr 2:196,327,149...196,375,154
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
increases expression |
ISO |
triphenyl phosphate results in increased expression of GPX1 mRNA |
CTD |
PMID:26049154 PMID:26183808 |
|
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Gramd2b |
GRAM domain containing 2B |
increases expression |
EXP |
triphenyl phosphate results in increased expression of GRAMD2B mRNA |
CTD |
PMID:30589522 |
|
NCBI chr18:49,884,014...49,981,955
Ensembl chr18:49,884,014...49,981,953
|
|
G |
Gramd4 |
GRAM domain containing 4 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of GRAMD4 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 7:117,150,398...117,224,056
Ensembl chr 7:117,150,374...117,224,053
|
|
G |
Grb7 |
growth factor receptor bound protein 7 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of GRB7 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr10:83,443,387...83,453,057
Ensembl chr10:83,444,004...83,453,052
|
|
G |
Grem2 |
gremlin 2, DAN family BMP antagonist |
increases expression |
EXP |
triphenyl phosphate results in increased expression of GREM2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr13:86,778,543...86,871,509
Ensembl chr13:86,778,500...86,871,615
|
|
G |
Grin1 |
glutamate ionotropic receptor NMDA type subunit 1 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of GRIN1 mRNA |
CTD |
PMID:33078273 |
|
NCBI chr 3:8,103,680...8,130,603
Ensembl chr 3:8,103,680...8,130,603
|
|
G |
Grin2a |
glutamate ionotropic receptor NMDA type subunit 2A |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of GRIN2A mRNA |
CTD |
PMID:33078273 |
|
NCBI chr10:5,630,684...6,043,341
Ensembl chr10:5,631,369...6,044,637
|
|
G |
Grin2c |
glutamate ionotropic receptor NMDA type subunit 2C |
increases expression |
EXP |
triphenyl phosphate results in increased expression of GRIN2C mRNA |
CTD |
PMID:33078273 |
|
NCBI chr10:100,488,430...100,507,083
Ensembl chr10:100,488,431...100,506,427
|
|
G |
Gskip |
GSK3B interacting protein |
increases expression |
EXP |
triphenyl phosphate results in increased expression of GSKIP mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 6:124,586,087...124,609,106
Ensembl chr 6:124,586,070...124,609,100
|
|
G |
Gsr |
glutathione-disulfide reductase |
increases expression |
EXP |
triphenyl phosphate results in increased expression of GSR mRNA |
CTD |
PMID:30974155 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Gsta2 |
glutathione S-transferase alpha 2 |
increases expression decreases expression |
EXP ISO |
triphenyl phosphate results in increased expression of GSTA2 mRNA triphenyl phosphate results in decreased expression of GSTA1 mRNA triphenyl phosphate results in increased expression of GSTA1 mRNA |
CTD |
PMID:26049154 PMID:26183808 PMID:30589522 |
|
NCBI chr 8:79,184,535...79,196,827
Ensembl chr 8:79,184,322...79,196,798
|
|
G |
Gsta3 |
glutathione S-transferase alpha 3 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of GSTA3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 9:23,658,574...23,684,240
Ensembl chr 9:23,658,574...23,684,240
|
|
G |
Gsta4 |
glutathione S-transferase alpha 4 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of GSTA4 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 8:79,066,967...79,084,193
Ensembl chr 8:79,066,934...79,084,182
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
affects expression |
EXP |
triphenyl phosphate affects the expression of GSTP1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Gstt1 |
glutathione S-transferase theta 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of GSTT1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
|
|
G |
Gtpbp4 |
GTP binding protein 4 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of GTPBP4 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr17:61,308,033...61,328,184
Ensembl chr17:61,308,014...61,418,009
|
|
G |
Gucy2c |
guanylate cyclase 2C |
affects expression |
EXP |
triphenyl phosphate affects the expression of GUCY2C mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 4:169,568,505...169,649,092
Ensembl chr 4:169,568,529...169,649,092
|
|
G |
Gyg1 |
glycogenin 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of GYG1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:102,611,888...102,653,916
Ensembl chr 2:102,598,496...102,653,797
|
|
G |
H1f0 |
H1.0 linker histone |
affects expression |
EXP |
triphenyl phosphate affects the expression of H1F0 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 7:110,592,834...110,594,694
Ensembl chr 7:110,592,208...110,594,694
|
|
G |
H2ac18 |
H2A clustered histone 18 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of H2AC18 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:183,808,398...183,808,922
|
|
G |
H2ax |
H2A.X variant histone |
increases expression |
ISO |
triphenyl phosphate results in increased expression of H2AX protein |
CTD |
PMID:36372259 |
|
NCBI chr 8:44,671,927...44,673,257
Ensembl chr 8:44,671,786...44,673,239
|
|
G |
Hacl1 |
2-hydroxyacyl-CoA lyase 1 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of HACL1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr16:6,826,881...6,863,027
Ensembl chr16:6,824,906...6,863,027
|
|
G |
Hal |
histidine ammonia lyase |
affects expression |
EXP |
triphenyl phosphate affects the expression of HAL mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 7:28,007,449...28,037,701
Ensembl chr 7:28,006,972...28,037,701
|
|
G |
Hao2 |
hydroxyacid oxidase 2 |
affects expression |
EXP |
triphenyl phosphate affects the expression of HAO2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:186,200,137...186,232,997
Ensembl chr 2:186,200,504...186,224,425
|
|
G |
Hapstr1 |
HUWE1 associated protein modifying stress responses |
increases expression |
EXP |
triphenyl phosphate results in increased expression of HAPSTR1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr10:6,746,037...6,774,992
Ensembl chr10:6,746,048...6,774,992
|
|
G |
Hba-a3 |
hemoglobin alpha, adult chain 3 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of HBA-A3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr10:15,311,637...15,312,481
Ensembl chr10:15,311,634...15,312,481
|
|
G |
Hbb |
hemoglobin subunit beta |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of HBB mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:158,250,421...158,251,832
Ensembl chr 1:158,120,200...158,252,012
|
|
G |
Hcfc2 |
host cell factor C2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of HCFC2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 7:20,983,986...21,019,826
Ensembl chr 7:20,991,017...21,019,801
|
|
G |
Hdac11 |
histone deacetylase 11 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of HDAC11 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 4:123,645,873...123,667,407
Ensembl chr 4:123,650,157...123,667,405
|
|
G |
Hdgf |
heparin binding growth factor |
affects expression |
EXP |
triphenyl phosphate affects the expression of HDGF mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:173,370,147...173,379,756
Ensembl chr 2:173,370,465...173,379,747
|
|
G |
Hecw2 |
HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of HECW2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 9:55,359,462...55,753,106
Ensembl chr 9:55,365,203...55,580,327
|
|
G |
Herc3 |
HECT and RLD domain containing E3 ubiquitin protein ligase 3 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of HERC3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 4:87,952,202...88,042,492
Ensembl chr 4:87,952,274...88,042,488
|
|
G |
Herpud1 |
homocysteine inducible ER protein with ubiquitin like domain 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of HERPUD1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr19:10,598,411...10,609,002
Ensembl chr19:10,598,417...10,618,424
|
|
G |
Hhex |
hematopoietically expressed homeobox |
increases expression |
EXP |
triphenyl phosphate results in increased expression of HHEX mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:235,190,455...235,196,042
Ensembl chr 1:235,190,455...235,196,042
|
|
G |
Hibch |
3-hydroxyisobutyryl-CoA hydrolase |
increases expression |
EXP |
triphenyl phosphate results in increased expression of HIBCH mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 9:48,590,097...48,669,896
Ensembl chr 9:48,590,099...48,669,824
|
|
G |
Hlcs |
holocarboxylase synthetase |
increases expression |
EXP |
triphenyl phosphate results in increased expression of HLCS mRNA |
CTD |
PMID:30589522 |
|
NCBI chr11:33,455,806...33,635,197
Ensembl chr11:33,455,809...33,624,222
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
increases expression |
ISO EXP |
triphenyl phosphate results in increased expression of HMGCR mRNA |
CTD |
PMID:30589522 PMID:30966736 |
|
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
|
|
G |
Hmgcs1 |
3-hydroxy-3-methylglutaryl-CoA synthase 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of HMGCS1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:51,649,368...51,667,100
Ensembl chr 2:51,649,497...51,667,100
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of HMOX1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hnrnpa2b1 |
heterogeneous nuclear ribonucleoprotein A2/B1 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of HNRNPA2B1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 4:80,534,659...80,545,297
Ensembl chr 4:80,534,651...80,545,249
|
|
G |
Hprt1 |
hypoxanthine phosphoribosyltransferase 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of HPRT1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr X:132,736,175...132,768,149
Ensembl chr X:132,736,096...132,768,154
|
|
G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
multiple interactions |
EXP |
[triphenyl phosphate co-treated with Flame Retardants] results in decreased expression of HSD11B2 mRNA |
CTD |
PMID:32243540 |
|
NCBI chr19:33,397,656...33,402,899
Ensembl chr19:33,397,656...33,402,899
|
|
G |
Hsd17b13 |
hydroxysteroid (17-beta) dehydrogenase 13 |
decreases expression multiple interactions |
ISO |
triphenyl phosphate results in decreased expression of HSD17B13 mRNA triphenyl phosphate inhibits the reaction [CGB3 protein results in increased expression of HSD17B13 mRNA] |
CTD |
PMID:26049154 PMID:26183808 |
|
NCBI chr14:5,751,697...5,766,809
Ensembl chr14:5,752,132...5,768,166
|
|
G |
Hsd17b2 |
hydroxysteroid (17-beta) dehydrogenase 2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of HSD17B2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr19:45,753,576...45,825,203
Ensembl chr19:45,753,574...45,825,202
|
|
G |
Hsd17b7 |
hydroxysteroid (17-beta) dehydrogenase 7 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of HSD17B7 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr13:82,170,079...82,190,018
Ensembl chr13:82,173,179...82,190,017
|
|
G |
Hsd3b1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
decreases expression multiple interactions increases expression |
ISO |
triphenyl phosphate results in decreased expression of HSD3B1 mRNA PPARG protein affects the reaction [triphenyl phosphate results in increased expression of HSD3B1 mRNA] |
CTD |
PMID:26049154 PMID:28282128 |
|
NCBI chr 2:186,169,864...186,175,984
Ensembl chr 2:186,169,863...186,175,999
|
|
G |
Htatip2 |
HIV-1 Tat interactive protein 2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of HTATIP2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:99,473,411...99,488,632
Ensembl chr 1:99,469,245...99,488,629
|
|
G |
Icoslg |
inducible T-cell co-stimulator ligand |
affects expression |
EXP |
triphenyl phosphate affects the expression of ICOSLG mRNA |
CTD |
PMID:30589522 |
|
NCBI chr20:10,600,420...10,610,718
Ensembl chr20:10,600,420...10,610,703
|
|
G |
Id4 |
inhibitor of DNA binding 4 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of ID4 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr17:16,389,387...16,391,956
Ensembl chr17:16,389,387...16,392,470
|
|
G |
Idi1 |
isopentenyl-diphosphate delta isomerase 1 |
affects expression |
EXP |
triphenyl phosphate affects the expression of IDI1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr17:61,629,592...61,637,357
Ensembl chr17:61,629,594...61,637,357
|
|
G |
Ifnar2 |
interferon alpha and beta receptor subunit 2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of IFNAR2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr11:30,613,576...30,645,958
Ensembl chr11:30,613,767...30,668,124
|
|
G |
Ifngr1 |
interferon gamma receptor 1 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of IFNGR1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:14,333,167...14,351,799
Ensembl chr 1:14,333,187...14,351,785
|
|
G |
Ift140 |
intraflagellar transport 140 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of IFT140 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr10:14,032,665...14,121,682
Ensembl chr10:14,032,648...14,120,433
|
|
G |
Ift25 |
intraflagellar transport 25 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of IFT25 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 5:122,035,588...122,062,421
Ensembl chr 5:122,035,581...122,062,421
|
|
G |
Ift81 |
intraflagellar transport 81 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of IFT81 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr12:33,957,744...34,037,164
Ensembl chr12:33,957,806...34,037,057
|
|
G |
Igf1 |
insulin-like growth factor 1 |
decreases expression affects expression |
ISO |
triphenyl phosphate results in decreased expression of IGF1 protein triphenyl phosphate affects the expression of IGF1 mRNA |
CTD |
PMID:29316351 |
|
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Igf1r |
insulin-like growth factor 1 receptor |
increases expression |
ISO |
triphenyl phosphate results in increased expression of IGF1R mRNA |
CTD |
PMID:29316351 |
|
NCBI chr 1:121,549,839...121,838,545
Ensembl chr 1:121,550,743...121,831,777
|
|
G |
Igf2 |
insulin-like growth factor 2 |
increases expression |
ISO |
triphenyl phosphate results in increased expression of IGF2 mRNA |
CTD |
PMID:29316351 |
|
NCBI chr 1:197,814,409...197,831,802
Ensembl chr 1:197,814,410...197,823,018
|
|
G |
Igf2r |
insulin-like growth factor 2 receptor |
increases expression |
EXP ISO |
triphenyl phosphate results in increased expression of IGF2R mRNA |
CTD |
PMID:29316351 PMID:30589522 |
|
NCBI chr 1:47,979,109...48,067,501
Ensembl chr 1:47,979,109...48,067,501
|
|
G |
Igfbp2 |
insulin-like growth factor binding protein 2 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of IGFBP2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 9:74,415,574...74,442,945
Ensembl chr 9:74,415,546...74,442,937
|
|
G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of IGFBP3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr14:82,056,347...82,064,083
Ensembl chr14:82,056,347...82,064,083
|
|
G |
Igkc |
immunoglobulin kappa constant |
affects expression |
EXP |
triphenyl phosphate affects the expression of IGKC mRNA |
CTD |
PMID:30589522 |
|
|
|
G |
Il15 |
interleukin 15 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of IL15 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr19:25,640,013...25,706,818
Ensembl chr19:25,640,251...25,706,820
|
|
G |
Il1r1 |
interleukin 1 receptor type 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of IL1R1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 9:42,504,917...42,580,958
Ensembl chr 9:42,504,735...42,579,937
|
|
G |
Il36b |
interleukin 36, beta |
increases expression |
EXP |
triphenyl phosphate results in increased expression of IL36B mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 3:7,024,862...7,122,489
Ensembl chr 3:7,021,973...7,031,619
|
|
G |
Inhba |
inhibin subunit beta A |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of INHBA mRNA |
CTD |
PMID:30589522 |
|
NCBI chr17:49,091,635...49,111,573
Ensembl chr17:49,095,920...49,108,982
|
|
G |
Inmt |
indolethylamine N-methyltransferase |
affects expression |
EXP |
triphenyl phosphate affects the expression of INMT mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 4:84,318,197...84,322,493
Ensembl chr 4:84,318,197...84,322,493
|
|
G |
Ins1 |
insulin 1 |
multiple interactions |
ISO |
[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS1 protein co-treated with triphenyl phosphate] results in decreased expression of SP7 mRNA; [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS1 protein co-treated with triphenyl phosphate] results in increased expression of FABP4 mRNA; [triphenyl phosphate co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA; [triphenyl phosphate co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CIDEC mRNA; [triphenyl phosphate co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ELOVL3 mRNA; [triphenyl phosphate co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FABP4 mRNA; [triphenyl phosphate co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PLIN1 mRNA; [triphenyl phosphate co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARA mRNA; [triphenyl phosphate co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA; [triphenyl phosphate co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased secretion of ADIPOQ protein; [tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in decreased expression of and results in decreased secretion of INS1 protein; ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in decreased expression of and results in decreased secretion of INS1 protein] |
CTD |
PMID:25062436 PMID:29112739 PMID:34323617 |
|
NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
|
|
G |
Ins2 |
insulin 2 |
multiple interactions |
ISO |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [triphenyl phosphate promotes the reaction [INS protein results in increased import of Glucose]]; triphenyl phosphate promotes the reaction [INS protein results in increased import of Glucose] 2-chloro-5-nitrobenzanilide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with triphenyl phosphate analog] results in increased expression of FABP4 mRNA]; 2-chloro-5-nitrobenzanilide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with triphenyl phosphate] results in increased expression of FABP4 mRNA]; [1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with triphenyl phosphate analog] results in increased expression of CEBPA mRNA; [1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with triphenyl phosphate analog] results in increased expression of FABP4 mRNA; [1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with triphenyl phosphate analog] results in increased expression of FABP4 protein; [1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with triphenyl phosphate analog] results in increased expression of LPL mRNA; [1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with triphenyl phosphate analog] results in increased expression of LPL protein; [1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with triphenyl phosphate analog] results in increased expression of PLIN1 mRNA; [1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with triphenyl phosphate analog] results in increased expression of PLIN1 protein; [1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with triphenyl phosphate analog] results in increased expression of PPARG mRNA; [1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with triphenyl phosphate] results in increased expression of CEBPA mRNA; [1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with triphenyl phosphate] results in increased expression of FABP4 mRNA; [1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with triphenyl phosphate] results in increased expression of FABP4 protein; [1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with triphenyl phosphate] results in increased expression of LPL mRNA; [1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with triphenyl phosphate] results in increased expression of LPL protein; [1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with triphenyl phosphate] results in increased expression of PLIN1 mRNA; [1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with triphenyl phosphate] results in increased expression of PLIN1 protein; [1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with triphenyl phosphate] results in increased expression of PPARG mRNA |
CTD |
PMID:28163246 PMID:28437481 |
|
NCBI chr 1:197,843,277...197,992,522
Ensembl chr 1:197,843,281...197,864,775
|
|
G |
Insig1 |
insulin induced gene 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of INSIG1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 4:7,315,494...7,323,972
Ensembl chr 4:7,315,495...7,323,952
|
|
G |
Insig2 |
insulin induced gene 2 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of INSIG2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr13:32,472,390...32,500,139
Ensembl chr13:32,473,742...32,494,923
|
|
G |
Insr |
insulin receptor |
multiple interactions increases expression |
ISO |
[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of INSR mRNA; [tris(1,3-dichloro-2-propyl)phosphate co-treated with Tritolyl Phosphates co-treated with triphenyl phosphate] results in decreased expression of INSR mRNA; ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of INSR mRNA] triphenyl phosphate results in increased expression of INSR mRNA |
CTD |
PMID:29112739 PMID:29316351 PMID:32360330 |
|
NCBI chr12:1,193,193...1,330,976
Ensembl chr12:1,197,100...1,330,883
|
|
G |
Ints6 |
integrator complex subunit 6 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of INTS6 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr15:36,908,966...37,048,043
Ensembl chr15:36,933,724...37,021,527
|
|
G |
Ipp |
intracisternal A particle-promoted polypeptide |
increases expression |
EXP |
triphenyl phosphate results in increased expression of IPP mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 5:129,962,528...130,001,237
Ensembl chr 5:129,962,643...130,001,242
|
|
G |
Irak1bp1 |
interleukin-1 receptor-associated kinase 1 binding protein 1 |
affects expression |
EXP |
triphenyl phosphate affects the expression of IRAK1BP1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 8:83,731,512...83,748,289
Ensembl chr 8:83,731,507...83,748,289
|
|
G |
Irak3 |
interleukin-1 receptor-associated kinase 3 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of IRAK3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 7:55,653,949...55,714,371
Ensembl chr 7:55,653,962...55,713,121
|
|
G |
Irf1 |
interferon regulatory factor 1 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of IRF1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr10:37,917,155...37,924,166
Ensembl chr10:37,916,670...37,924,166
|
|
G |
Irs1 |
insulin receptor substrate 1 |
increases expression |
ISO |
triphenyl phosphate results in increased expression of IRS1 mRNA |
CTD |
PMID:29316351 |
|
NCBI chr 9:83,552,964...83,605,797
Ensembl chr 9:83,548,944...83,606,122
|
|
G |
Irs2 |
insulin receptor substrate 2 |
affects expression |
ISO EXP |
triphenyl phosphate affects the expression of IRS2 mRNA |
CTD |
PMID:29316351 PMID:30589522 |
|
NCBI chr16:78,488,249...78,512,482
Ensembl chr16:78,485,045...78,512,482
|
|
G |
Irx1 |
iroquois homeobox 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of IRX1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:31,294,615...31,300,444
Ensembl chr 1:31,294,615...31,300,444
|
|
G |
Isg20 |
interferon stimulated exonuclease gene 20 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ISG20 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:132,829,303...132,837,027
Ensembl chr 1:132,815,123...132,837,027
|
|
G |
Isyna1 |
inositol-3-phosphate synthase 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ISYNA1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr16:18,839,143...18,841,979
Ensembl chr16:18,839,145...18,841,979
|
|
G |
Itgb2 |
integrin subunit beta 2 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of ITGB2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr20:11,061,394...11,097,656
Ensembl chr20:11,061,430...11,097,600
|
|
G |
Itih1 |
inter-alpha trypsin inhibitor, heavy chain 1 |
increases expression |
ISO |
triphenyl phosphate results in increased expression of ITIH1 mRNA |
CTD |
PMID:28934090 |
|
NCBI chr16:6,122,246...6,136,363
Ensembl chr16:6,122,248...6,136,363
|
|
G |
Itih5 |
inter-alpha-trypsin inhibitor heavy chain 5 |
increases expression |
ISO |
triphenyl phosphate results in increased expression of ITIH5 mRNA |
CTD |
PMID:28934090 |
|
NCBI chr17:68,248,115...68,352,216
Ensembl chr17:68,252,128...68,352,207
|
|
G |
Itsn2 |
intersectin 2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ITSN2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 6:27,616,645...27,727,373
Ensembl chr 6:27,600,406...27,727,124
|
|
G |
Jade1 |
jade family PHD finger 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of JADE1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:124,543,259...124,596,361
Ensembl chr 2:124,543,286...124,596,354
|
|
G |
Jcad |
junctional cadherin 5 associated |
affects expression |
EXP |
triphenyl phosphate affects the expression of JCAD mRNA |
CTD |
PMID:30589522 |
|
NCBI chr17:53,089,382...53,130,996
Ensembl chr17:53,089,382...53,130,967
|
|
G |
Jchain |
joining chain of multimeric IgA and IgM |
affects expression |
EXP |
triphenyl phosphate affects the expression of JCHAIN mRNA |
CTD |
PMID:30589522 |
|
NCBI chr14:19,538,560...19,546,384
Ensembl chr14:19,538,952...19,546,298
|
|
G |
Jpt2 |
Jupiter microtubule associated homolog 2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of JPT2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr10:13,963,135...13,983,212
Ensembl chr10:13,963,137...13,983,170
|
|
G |
Kank2 |
KN motif and ankyrin repeat domains 2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of KANK2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 8:20,311,676...20,341,107
Ensembl chr 8:20,311,676...20,340,900
|
|
G |
Kcnq2 |
potassium voltage-gated channel subfamily Q member 2 |
multiple interactions |
ISO |
[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of KCNQ2 mRNA; ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of KCNQ2 mRNA] |
CTD |
PMID:29112739 |
|
NCBI chr 3:168,194,776...168,253,831
Ensembl chr 3:168,195,357...168,275,071
|
|
G |
Kcnq3 |
potassium voltage-gated channel subfamily Q member 3 |
multiple interactions |
ISO |
[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of KCNQ3 mRNA; ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of KCNQ3 mRNA] |
CTD |
PMID:29112739 |
|
NCBI chr 7:97,730,219...98,025,652
Ensembl chr 7:97,730,465...98,025,653
|
|
G |
Kcnq5 |
potassium voltage-gated channel subfamily Q member 5 |
multiple interactions |
ISO |
[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of KCNQ5 mRNA; ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of KCNQ5 mRNA] |
CTD |
PMID:29112739 |
|
NCBI chr 9:23,830,185...24,395,984
Ensembl chr 9:23,833,087...24,394,704
|
|
G |
Khnyn |
KH and NYN domain containing |
increases expression |
EXP |
triphenyl phosphate results in increased expression of KHNYN mRNA |
CTD |
PMID:30589522 |
|
NCBI chr15:29,365,399...29,379,650
Ensembl chr15:29,365,260...29,376,967
|
|
G |
Kif11 |
kinesin family member 11 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of KIF11 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:235,124,371...235,176,760
Ensembl chr 1:235,124,316...235,176,766
|
|
G |
Kif20b |
kinesin family member 20B |
increases expression |
EXP |
triphenyl phosphate results in increased expression of KIF20B mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:232,428,293...232,483,798
Ensembl chr 1:232,428,371...232,483,787
|
|
G |
Kif21a |
kinesin family member 21A |
increases expression |
EXP |
triphenyl phosphate results in increased expression of KIF21A mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 7:122,062,523...122,179,051
Ensembl chr 7:122,062,537...122,178,999
|
|
G |
Kif23 |
kinesin family member 23 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of KIF23 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 8:62,397,908...62,425,162
Ensembl chr 8:62,397,948...62,425,072
|
|
G |
Kiss1 |
KiSS-1 metastasis-suppressor |
multiple interactions |
ISO |
[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of KISS1 mRNA; [tris(1,3-dichloro-2-propyl)phosphate co-treated with Tritolyl Phosphates co-treated with triphenyl phosphate] results in decreased expression of KISS1 mRNA; ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of KISS1 mRNA] |
CTD |
PMID:29112739 PMID:32360330 |
|
NCBI chr13:44,774,823...44,780,707
Ensembl chr13:44,774,823...44,780,612
|
|
G |
Klf11 |
KLF transcription factor 11 |
affects expression |
EXP |
triphenyl phosphate affects the expression of KLF11 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 6:41,285,699...41,297,548
Ensembl chr 6:41,285,842...41,297,550
|
|
G |
Klf13 |
KLF transcription factor 13 |
affects expression |
EXP |
triphenyl phosphate affects the expression of KLF13 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:117,505,857...117,536,626
Ensembl chr 1:117,503,602...117,551,227
|
|
G |
Klf15 |
KLF transcription factor 15 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of KLF15 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 4:122,965,718...122,978,403
Ensembl chr 4:122,965,807...122,978,374
|
|
G |
Klf16 |
KLF transcription factor 16 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of KLF16 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 7:9,138,503...9,148,322
Ensembl chr 7:9,138,503...9,148,317
|
|
G |
Klf6 |
KLF transcription factor 6 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of KLF6 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr17:64,539,456...64,548,451
Ensembl chr17:64,531,463...64,588,570
|
|
G |
Klhdc8a |
kelch domain containing 8A |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of KLHDC8A mRNA |
CTD |
PMID:30589522 |
|
NCBI chr13:43,735,702...43,744,277
Ensembl chr13:43,736,192...43,744,277
|
|
G |
Kmt5a |
lysine methyltransferase 5A |
affects expression |
EXP |
triphenyl phosphate affects the expression of KMT5A mRNA |
CTD |
PMID:30589522 |
|
NCBI chr12:32,139,353...32,167,777
Ensembl chr12:32,139,178...32,162,711
|
|
G |
Krcc1 |
lysine-rich coiled-coil 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of KRCC1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 4:103,261,566...103,274,672
Ensembl chr 4:103,261,536...103,277,156
|
|
G |
Krt18 |
keratin 18 |
decreases expression |
ISO |
triphenyl phosphate results in decreased expression of KRT18 mRNA |
CTD |
PMID:28934090 |
|
NCBI chr 7:133,157,486...133,161,162
Ensembl chr 7:133,157,475...133,161,166
|
|
G |
Kyat1 |
kynurenine aminotransferase 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of KYAT1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 3:13,459,598...13,493,308
Ensembl chr 3:13,459,591...13,493,355
|
|
G |
Kynu |
kynureninase |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of KYNU mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 3:27,778,646...27,929,470
Ensembl chr 3:27,778,772...27,929,488
|
|
G |
L3hypdh |
trans-L-3-hydroxyproline dehydratase |
increases expression |
EXP |
triphenyl phosphate results in increased expression of L3HYPDH mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 6:90,636,310...90,647,106
Ensembl chr 6:90,636,310...90,647,106
|
|
G |
Lactb2 |
lactamase, beta 2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of LACTB2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 5:5,569,080...5,591,843
Ensembl chr 5:5,569,067...5,596,429
|
|
G |
Lama3 |
laminin subunit alpha 3 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of LAMA3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr18:3,523,168...3,751,722
Ensembl chr18:3,523,133...3,751,353
|
|
G |
Laptm5 |
lysosomal protein transmembrane 5 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of LAPTM5 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 5:143,087,759...143,109,807
Ensembl chr 5:143,087,759...143,109,807
|
|
G |
Larp1b |
La ribonucleoprotein 1B |
affects expression |
EXP |
triphenyl phosphate affects the expression of LARP1B mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:123,936,074...123,969,254
Ensembl chr 2:123,935,983...123,968,896
|
|
G |
Ldhd |
lactate dehydrogenase D |
increases expression |
EXP |
triphenyl phosphate results in increased expression of LDHD mRNA |
CTD |
PMID:30589522 |
|
NCBI chr19:39,573,621...39,595,575
Ensembl chr19:39,573,621...39,595,575
|
|
G |
Ldlr |
low density lipoprotein receptor |
increases expression decreases expression |
ISO |
triphenyl phosphate results in increased expression of LDLR mRNA triphenyl phosphate results in decreased expression of LDLR mRNA |
CTD |
PMID:26049154 PMID:26183808 PMID:28934090 |
|
NCBI chr 8:20,270,020...20,292,981
Ensembl chr 8:20,270,041...20,294,580
|
|
G |
Lect2 |
leukocyte cell-derived chemotaxin 2 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of LECT2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr17:8,044,759...8,050,983
Ensembl chr17:8,044,759...8,050,983
|
|
G |
Lep |
leptin |
multiple interactions |
ISO |
[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in decreased expression of and results in decreased secretion of LEP protein; ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in decreased expression of and results in decreased secretion of LEP protein] |
CTD |
PMID:29112739 |
|
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
|
|
G |
Lepr |
leptin receptor |
multiple interactions |
ISO |
[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of LEPR mRNA; [tris(1,3-dichloro-2-propyl)phosphate co-treated with Tritolyl Phosphates co-treated with triphenyl phosphate] results in decreased expression of LEPR mRNA; ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of LEPR mRNA] |
CTD |
PMID:29112739 PMID:32360330 |
|
NCBI chr 5:116,294,409...116,477,904
Ensembl chr 5:116,289,823...116,475,908
|
|
G |
Lgalsl |
galectin-like |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of LGALSL mRNA |
CTD |
PMID:30589522 |
|
NCBI chr14:94,996,991...95,004,499
Ensembl chr14:94,996,990...95,004,980
|
|
G |
Lhfpl2 |
LHFPL tetraspan subfamily member 2 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of LHFPL2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:25,281,771...25,428,128
Ensembl chr 2:25,281,901...25,427,950
|
|
G |
Lhfpl6 |
LHFPL tetraspan subfamily member 6 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of LHFPL6 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:137,126,485...137,324,442
Ensembl chr 2:137,126,509...137,324,443
|
|
G |
Lima1 |
LIM domain and actin binding 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of LIMA1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 7:130,901,717...131,001,573
Ensembl chr 7:130,901,717...131,001,473
|
|
G |
Lin54 |
lin-54 DREAM MuvB core complex component |
increases expression |
EXP |
triphenyl phosphate results in increased expression of LIN54 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr14:9,129,775...9,188,244
Ensembl chr14:9,130,336...9,187,790
|
|
G |
Lipc |
lipase C, hepatic type |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of LIPC mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 8:71,509,633...71,635,663
Ensembl chr 8:71,509,635...71,635,464
|
|
G |
Lmnb1 |
lamin B1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of LMNB1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr18:50,175,861...50,215,210
Ensembl chr18:50,175,874...50,214,502
|
|
G |
Lnx2 |
ligand of numb-protein X 2 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of LNX2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr12:8,005,202...8,070,494
Ensembl chr12:8,005,227...8,070,494
|
|
G |
Lox |
lysyl oxidase |
affects expression |
EXP |
triphenyl phosphate affects the expression of LOX mRNA |
CTD |
PMID:30589522 |
|
NCBI chr18:45,964,311...46,041,477
Ensembl chr18:45,967,343...46,041,477
|
|
G |
Lpin1 |
lipin 1 |
affects expression |
EXP |
triphenyl phosphate affects the expression of LPIN1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 6:39,309,198...39,417,034
Ensembl chr 6:39,312,748...39,417,097
|
|
G |
Lpin2 |
lipin 2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of LPIN2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 9:111,083,378...111,158,193
Ensembl chr 9:111,083,745...111,158,193
|
|
G |
Lpl |
lipoprotein lipase |
increases expression decreases expression multiple interactions |
ISO EXP |
triphenyl phosphate results in increased expression of LPL mRNA triphenyl phosphate results in decreased expression of LPL mRNA [1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with triphenyl phosphate analog] results in increased expression of LPL mRNA; [1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with triphenyl phosphate analog] results in increased expression of LPL protein; [1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with triphenyl phosphate] results in increased expression of LPL mRNA; [1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with triphenyl phosphate] results in increased expression of LPL protein |
CTD |
PMID:28163246 PMID:28437481 PMID:28934090 PMID:30589522 |
|
NCBI chr16:20,830,055...20,853,855
Ensembl chr16:20,829,465...20,855,249
|
|
G |
Lrat |
lecithin retinol acyltransferase |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of LRAT mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:168,264,093...168,273,155
Ensembl chr 2:168,266,877...168,273,619
|
|
G |
Lrrc51 |
leucine rich repeat containing 51 |
affects expression |
EXP |
triphenyl phosphate affects the expression of LRRC51 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:156,278,617...156,297,838
Ensembl chr 1:156,278,618...156,297,773
|
|
G |
Lsm11 |
LSM11, U7 small nuclear RNA associated |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of LSM11 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr10:30,367,841...30,385,956
Ensembl chr10:30,370,727...30,385,944
|
|
G |
Lsm8 |
LSM8 homolog, U6 small nuclear RNA associated |
increases expression |
EXP |
triphenyl phosphate results in increased expression of LSM8 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 4:47,306,259...47,312,125
Ensembl chr 4:47,306,295...47,314,293
|
|
G |
Lss |
lanosterol synthase |
affects expression |
EXP |
triphenyl phosphate affects the expression of LSS mRNA |
CTD |
PMID:30589522 |
|
NCBI chr20:12,091,138...12,118,858
Ensembl chr20:12,092,774...12,118,762
|
|
G |
Ltbp1 |
latent transforming growth factor beta binding protein 1 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of LTBP1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 6:20,029,629...20,425,339
Ensembl chr 6:20,029,629...20,425,349
|
|
G |
Lurap1l |
leucine rich adaptor protein 1-like |
increases expression |
EXP |
triphenyl phosphate results in increased expression of LURAP1L mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 5:95,362,005...95,409,439
Ensembl chr 5:95,362,005...95,409,438
|
|
G |
Lyrm2 |
LYR motif containing 2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of LYRM2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 5:47,198,192...47,200,470
Ensembl chr 5:47,198,185...47,201,611
|
|
G |
Lyst |
lysosomal trafficking regulator |
increases expression |
EXP |
triphenyl phosphate results in increased expression of LYST mRNA |
CTD |
PMID:30589522 |
|
NCBI chr17:86,241,384...86,443,501
Ensembl chr17:86,241,384...86,443,480
|
|
G |
Lyz2 |
lysozyme 2 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of LYZ2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 7:52,906,810...52,912,154
Ensembl chr 7:52,906,811...52,912,106
|
|
G |
Mab21l3 |
mab-21 like 3 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of MAB21L3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:189,248,895...189,271,652
Ensembl chr 2:189,248,895...189,271,652
|
|
G |
Mad2l1bp |
MAD2L1 binding protein |
increases expression |
EXP |
triphenyl phosphate results in increased expression of MAD2L1BP mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 9:14,832,133...14,836,458
Ensembl chr 9:14,832,132...14,837,447
|
|
G |
Mafb |
MAF bZIP transcription factor B |
increases expression |
EXP |
triphenyl phosphate results in increased expression of MAFB mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 3:148,998,111...149,000,031
Ensembl chr 3:148,998,122...149,000,031
|
|
G |
Maff |
MAF bZIP transcription factor F |
increases expression |
EXP |
triphenyl phosphate results in increased expression of MAFF mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 7:110,912,499...110,923,851
Ensembl chr 7:110,912,499...110,923,851
|
|
G |
Mag |
myelin-associated glycoprotein |
increases expression |
EXP |
triphenyl phosphate results in increased expression of MAG mRNA |
CTD |
PMID:33078273 |
|
NCBI chr 1:86,148,227...86,163,726
Ensembl chr 1:86,148,228...86,163,656
|
|
G |
Magi3 |
membrane associated guanylate kinase, WW and PDZ domain containing 3 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of MAGI3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:191,514,726...191,717,048
Ensembl chr 2:191,518,506...191,716,735
|
|
G |
Mak16 |
MAK16 homolog |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of MAK16 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr16:60,972,699...60,981,250
Ensembl chr16:60,972,697...60,983,243
|
|
G |
Mal2 |
mal, T-cell differentiation protein 2 |
affects expression |
EXP |
triphenyl phosphate affects the expression of MAL2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 7:85,900,453...85,933,433
Ensembl chr 7:85,900,453...85,933,429
|
|
G |
Malsu1 |
mitochondrial assembly of ribosomal large subunit 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of MALSU1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 4:78,051,090...78,059,913
Ensembl chr 4:78,051,059...78,059,905
|
|
G |
Mamdc2 |
MAM domain containing 2 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of MAMDC2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:220,863,959...221,016,493
Ensembl chr 1:220,863,976...221,016,354
|
|
G |
Manba |
mannosidase beta |
increases expression |
EXP |
triphenyl phosphate results in increased expression of MANBA mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:223,910,432...224,002,988
Ensembl chr 2:223,910,432...224,002,983
|
|
G |
Map2 |
microtubule-associated protein 2 |
decreases expression |
ISO |
triphenyl phosphate results in decreased expression of MAP2 mRNA |
CTD |
PMID:35752650 |
|
NCBI chr 9:67,723,422...67,981,886
Ensembl chr 9:67,723,371...67,979,809
|
|
G |
Map2k3 |
mitogen activated protein kinase kinase 3 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of MAP2K3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr10:45,608,145...45,629,492
Ensembl chr10:45,607,163...45,629,492
|
|
G |
Map4k1 |
mitogen activated protein kinase kinase kinase kinase 1 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of MAP4K1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:84,270,951...84,292,496
Ensembl chr 1:84,271,069...84,292,493
|
|
G |
Mapre3 |
microtubule-associated protein, RP/EB family, member 3 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of MAPRE3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 6:25,513,800...25,558,876
Ensembl chr 6:25,513,800...25,558,881
|
|
G |
Marchf3 |
membrane associated ring-CH-type finger 3 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of MARCHF3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr18:50,237,218...50,389,343
Ensembl chr18:50,237,230...50,389,150
|
|
G |
Marcks |
myristoylated alanine rich protein kinase C substrate |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of MARCKS mRNA |
CTD |
PMID:30589522 |
|
NCBI chr20:40,685,315...40,691,012
Ensembl chr20:40,685,315...40,691,012
|
|
G |
Mbnl3 |
muscleblind-like splicing regulator 3 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of MBNL3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr X:130,641,942...130,737,179
Ensembl chr X:130,648,538...130,737,056
|
|
G |
Mbp |
myelin basic protein |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of MBP mRNA |
CTD |
PMID:33078273 |
|
NCBI chr18:75,855,878...75,966,404
Ensembl chr18:75,855,878...75,966,404
|
|
G |
Mcc |
MCC regulator of WNT signaling pathway |
decreases expression |
ISO |
triphenyl phosphate results in decreased expression of MCC mRNA |
CTD |
PMID:35776891 |
|
NCBI chr18:36,794,206...37,266,237
Ensembl chr18:36,798,372...37,266,819
|
|
G |
Mcm2 |
minichromosome maintenance complex component 2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of MCM2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 4:121,346,434...121,360,962
Ensembl chr 4:121,346,434...121,360,847
|
|
G |
Mcm4 |
minichromosome maintenance complex component 4 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of MCM4 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr11:85,258,443...85,272,144
Ensembl chr11:85,258,443...85,272,144
|
|
G |
Mcoln1 |
mucolipin TRP cation channel 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of MCOLN1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr12:1,560,341...1,574,252
Ensembl chr12:1,560,359...1,574,252
|
|
G |
Mdc1 |
mediator of DNA damage checkpoint 1 |
affects expression |
EXP |
triphenyl phosphate affects the expression of MDC1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr20:2,893,693...2,912,394
Ensembl chr20:2,895,505...2,910,240
|
|
G |
Mdfic |
MyoD family inhibitor domain containing |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of MDFIC mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 4:43,972,310...44,052,162
Ensembl chr 4:43,972,507...44,052,161
|
|
G |
Mdm2 |
MDM2 proto-oncogene |
increases expression |
EXP |
triphenyl phosphate results in increased expression of MDM2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 7:53,290,660...53,315,205
Ensembl chr 7:53,290,664...53,314,915
|
|
G |
Mdn1 |
midasin AAA ATPase 1 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of MDN1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 5:47,055,435...47,190,426
Ensembl chr 5:47,055,447...47,186,332
|
|
G |
Me1 |
malic enzyme 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ME1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 8:87,549,043...87,660,251
Ensembl chr 8:87,549,043...87,660,304
|
|
G |
Memo1 |
mediator of cell motility 1 |
affects expression |
EXP |
triphenyl phosphate affects the expression of MEMO1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 6:21,144,525...21,234,363
Ensembl chr 6:21,125,639...21,234,561
|
|
G |
Meox2 |
mesenchyme homeobox 2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of MEOX2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 6:53,856,760...53,917,467
Ensembl chr 6:53,856,758...53,917,467
|
|
G |
Mettl15 |
methyltransferase 15, mitochondrial 12S rRNA N4-cytidine |
increases expression |
EXP |
triphenyl phosphate results in increased expression of METTL15 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 3:95,586,855...95,764,392
Ensembl chr 3:95,586,850...95,764,397
|
|
G |
Mgll |
monoglyceride lipase |
increases expression affects expression |
ISO EXP |
triphenyl phosphate results in increased expression of MGLL mRNA triphenyl phosphate affects the expression of MGLL mRNA |
CTD |
PMID:28163246 PMID:30589522 |
|
NCBI chr 4:121,192,187...121,294,187
Ensembl chr 4:121,192,195...121,294,179
|
|
G |
Mgst2 |
microsomal glutathione S-transferase 2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of MGST2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:135,679,524...135,715,828
Ensembl chr 2:135,693,557...135,715,828
|
|
G |
Mical2 |
microtubule associated monooxygenase, calponin and LIM domain containing 2 |
decreases expression increases expression |
EXP ISO |
triphenyl phosphate results in decreased expression of MICAL2 mRNA triphenyl phosphate results in increased expression of MICAL2 mRNA |
CTD |
PMID:30589522 PMID:35776891 |
|
NCBI chr 1:166,345,853...166,471,715 NCBI chr 1:166,491,721...166,530,575
Ensembl chr 1:166,345,859...166,471,719
|
|
G |
Mid1ip1 |
MID1 interacting protein 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of MID1IP1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr X:12,060,993...12,063,318
Ensembl chr X:12,060,883...12,065,774
|
|
G |
Mindy2 |
MINDY lysine 48 deubiquitinase 2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of FAM63B mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 8:71,268,274...71,327,698
Ensembl chr 8:71,256,447...71,328,453
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of MKI67 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
|
|
G |
Mknk2 |
MAPK interacting serine/threonine kinase 2 |
affects expression |
EXP |
triphenyl phosphate affects the expression of MKNK2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 7:9,039,771...9,050,832
Ensembl chr 7:9,039,728...9,050,827
|
|
G |
Mlec |
malectin |
increases expression |
EXP |
triphenyl phosphate results in increased expression of MLEC mRNA |
CTD |
PMID:30589522 |
|
NCBI chr12:41,458,234...41,468,710
Ensembl chr12:41,458,231...41,468,708
|
|
G |
Mlh3 |
mutL homolog 3 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of MLH3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 6:104,881,483...104,917,686
Ensembl chr 6:104,881,483...104,917,728
|
|
G |
Mllt3 |
MLLT3, super elongation complex subunit |
increases expression |
EXP |
triphenyl phosphate results in increased expression of MLLT3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 5:102,259,075...102,515,447
Ensembl chr 5:102,260,011...102,515,361
|
|
G |
Mlxip |
MLX interacting protein |
increases expression |
ISO |
triphenyl phosphate results in increased expression of MLXIP mRNA |
CTD |
PMID:36563926 |
|
NCBI chr12:33,128,524...33,192,300
Ensembl chr12:33,128,520...33,192,374
|
|
G |
Mme |
membrane metallo-endopeptidase |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of MME mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:147,686,913...147,803,808
Ensembl chr 2:147,722,086...147,803,792
|
|
G |
Mmgt1 |
membrane magnesium transporter 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of MMGT1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr X:134,408,463...134,420,798
Ensembl chr X:134,408,466...134,420,729
|
|
G |
Mmp14 |
matrix metallopeptidase 14 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of MMP14 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr15:27,887,795...27,897,020
Ensembl chr15:27,887,727...27,899,864
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
affects expression |
EXP |
triphenyl phosphate affects the expression of MMP2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mnd1 |
meiotic nuclear divisions 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of MND1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:169,433,538...169,496,081
Ensembl chr 2:169,433,540...169,496,096
|
|
G |
Mocs2 |
molybdenum cofactor synthesis 2 |
affects expression |
EXP |
triphenyl phosphate affects the expression of MOCS2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:46,504,574...46,516,327
Ensembl chr 2:46,504,588...46,516,324
|
|
G |
Mpdz |
multiple PDZ domain crumbs cell polarity complex component |
increases expression |
EXP |
triphenyl phosphate results in increased expression of MPDZ mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 5:95,766,112...95,920,531
Ensembl chr 5:95,766,118...95,920,499
|
|
G |
Mpv17l |
MPV17 mitochondrial inner membrane protein like |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of MPV17L mRNA |
CTD |
PMID:30589522 |
|
NCBI chr10:1,988,451...2,025,300
Ensembl chr10:1,988,136...2,007,649
|
|
G |
Mrc1 |
mannose receptor, C type 1 |
decreases expression |
ISO |
triphenyl phosphate results in decreased expression of MRC1 mRNA |
CTD |
PMID:35752650 |
|
NCBI chr17:77,249,187...77,330,857
Ensembl chr17:77,249,187...77,330,857
|
|
G |
Mrnip |
MRN complex interacting protein |
increases expression |
EXP |
triphenyl phosphate results in increased expression of MRNIP mRNA |
CTD |
PMID:30589522 |
|
NCBI chr10:34,501,359...34,525,474
Ensembl chr10:34,501,384...34,525,469
|
|
G |
Msmo1 |
methylsterol monooxygenase 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of MSMO1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr16:24,980,680...24,997,927
Ensembl chr16:24,980,697...24,998,016
|
|
G |
Mt1 |
metallothionein 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of MT1F mRNA |
CTD |
PMID:30589522 |
|
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049
|
|
G |
Mt2A |
metallothionein 2A |
increases expression |
EXP |
triphenyl phosphate results in increased expression of MT2A mRNA |
CTD |
PMID:30589522 |
|
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
|
|
G |
Mtdh |
metadherin |
affects expression |
EXP |
triphenyl phosphate affects the expression of MTDH mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 7:65,306,464...65,365,647
Ensembl chr 7:65,306,400...65,364,413
|
|
G |
Mterf2 |
mitochondrial transcription termination factor 2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of MTERF2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 7:18,598,202...18,608,278
Ensembl chr 7:18,598,103...18,620,684
|
|
G |
Muc1 |
mucin 1, cell surface associated |
increases expression |
ISO |
triphenyl phosphate results in increased expression of MUC1 mRNA |
CTD |
PMID:28282128 |
|
NCBI chr 2:174,635,559...174,640,738
Ensembl chr 2:174,635,995...174,640,733
|
|
G |
Mvd |
mevalonate diphosphate decarboxylase |
increases expression |
EXP |
triphenyl phosphate results in increased expression of MVD mRNA |
CTD |
PMID:30589522 |
|
NCBI chr19:50,496,366...50,506,389
Ensembl chr19:50,496,367...50,507,971
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
increases expression |
EXP ISO |
triphenyl phosphate results in increased expression of MYC mRNA |
CTD |
PMID:30589522 PMID:35776891 |
|
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Myh11 |
myosin heavy chain 11 |
decreases expression |
ISO |
triphenyl phosphate results in decreased expression of MYH11 mRNA |
CTD |
PMID:28934090 |
|
NCBI chr10:743,364...838,459
Ensembl chr10:743,685...838,459
|
|
G |
Mylk |
myosin light chain kinase |
affects expression |
EXP |
triphenyl phosphate affects the expression of MYLK mRNA |
CTD |
PMID:30589522 |
|
NCBI chr11:65,783,008...66,030,239
Ensembl chr11:65,783,008...66,030,261
|
|
G |
N4bp2l1 |
NEDD4 binding protein 2-like 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of N4BP2L1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr12:102,572...128,352
Ensembl chr12:102,573...127,257
|
|
G |
Nab2 |
Ngfi-A binding protein 2 |
affects expression |
EXP |
triphenyl phosphate affects the expression of NAB2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 7:63,497,589...63,504,105
Ensembl chr 7:63,497,589...63,503,989
|
|
G |
Nabp1 |
nucleic acid binding protein 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of NABP1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 9:50,098,552...50,133,982
Ensembl chr 9:50,126,726...50,134,107
|
|
G |
Nacc2 |
NACC family member 2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of NACC2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 3:8,879,952...8,946,660
Ensembl chr 3:8,883,065...8,946,660
|
|
G |
Nap1l1 |
nucleosome assembly protein 1-like 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of NAP1L1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 7:46,933,278...46,957,853
Ensembl chr 7:46,933,356...46,956,593
|
|
G |
Nav2 |
neuron navigator 2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of NAV2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:98,957,629...99,322,339
Ensembl chr 1:98,663,759...99,322,337
|
|
G |
Nckap1l |
NCK associated protein 1 like |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of NCKAP1L mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 7:134,577,443...134,622,934
Ensembl chr 7:134,577,482...134,622,934
|
|
G |
Ndrg1 |
N-myc downstream regulated 1 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of NDRG1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 7:98,684,487...98,725,869
Ensembl chr 7:98,684,487...98,725,880
|
|
G |
Nedd4l |
NEDD4 like E3 ubiquitin protein ligase |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of NEDD4L mRNA |
CTD |
PMID:30589522 |
|
NCBI chr18:58,393,759...58,726,709
Ensembl chr18:58,393,509...58,723,137
|
|
G |
Nedd9 |
neural precursor cell expressed, developmentally down-regulated 9 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of NEDD9 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr17:23,289,793...23,468,026
Ensembl chr17:23,282,326...23,468,019
|
|
G |
Nefh |
neurofilament heavy chain |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of NEFH mRNA |
CTD |
PMID:33078273 |
|
NCBI chr14:79,830,362...79,840,347
Ensembl chr14:79,830,362...79,840,351
|
|
G |
Nes |
nestin |
increases expression decreases expression |
EXP ISO |
triphenyl phosphate results in increased expression of NES mRNA triphenyl phosphate results in decreased expression of NES mRNA |
CTD |
PMID:33078273 PMID:35752650 |
|
NCBI chr 2:173,437,867...173,447,777
Ensembl chr 2:173,438,734...173,447,777
|
|
G |
Neu2 |
neuraminidase 2 |
affects expression |
EXP |
triphenyl phosphate affects the expression of NEU2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 9:88,218,494...88,267,356
Ensembl chr 9:88,249,135...88,267,355
|
|
G |
Nfe2 |
nuclear factor, erythroid 2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of NFE2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 7:134,382,758...134,395,364
Ensembl chr 7:134,382,761...134,390,108
|
|
G |
Nfe2l1 |
NFE2 like bZIP transcription factor 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of NFE2L1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr10:81,796,055...81,812,926
Ensembl chr10:81,800,366...81,832,318
|
|
G |
Nfil3 |
nuclear factor, interleukin 3 regulated |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of NFIL3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr17:12,280,499...12,295,728
Ensembl chr17:12,280,484...12,295,858
|
|
G |
Nfix |
nuclear factor I X |
increases expression |
EXP |
triphenyl phosphate results in increased expression of NFIX mRNA |
CTD |
PMID:30589522 |
|
NCBI chr19:23,355,388...23,450,360
Ensembl chr19:23,355,498...23,448,265
|
|
G |
Nfyb |
nuclear transcription factor Y subunit beta |
increases expression |
EXP |
triphenyl phosphate results in increased expression of NFYB mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 7:20,964,988...20,980,569
Ensembl chr 7:20,964,993...20,980,565
|
|
G |
Nim1k |
NIM1 serine/threonine protein kinase |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of NIM1K mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:51,670,764...51,714,782
Ensembl chr 2:51,670,772...51,714,762
|
|
G |
Nipbl |
NIPBL, cohesin loading factor |
affects expression |
EXP |
triphenyl phosphate affects the expression of NIPBL mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:57,399,443...57,586,770
Ensembl chr 2:57,399,445...57,565,899
|
|
G |
Nkx2-1 |
NK2 homeobox 1 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of NKX2-1 mRNA |
CTD |
PMID:25646720 |
|
NCBI chr 6:73,996,601...74,001,483
Ensembl chr 6:73,996,601...73,999,791
|
|
G |
Nln |
neurolysin |
increases expression |
EXP |
triphenyl phosphate results in increased expression of NLN mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:35,133,634...35,232,927
Ensembl chr 2:35,134,145...35,232,914
|
|
G |
Nlrc5 |
NLR family, CARD domain containing 5 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of NLRC5 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr19:10,477,638...10,581,023
Ensembl chr19:10,477,628...10,562,121
|
|
G |
Nmrk1 |
nicotinamide riboside kinase 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of NMRK1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:216,049,350...216,076,792
Ensembl chr 1:216,049,437...216,076,791
|
|
G |
Noct |
nocturnin |
affects expression |
EXP |
triphenyl phosphate affects the expression of NOCT mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:135,271,189...135,291,407
Ensembl chr 2:135,271,189...135,291,400
|
|
G |
Nol8 |
nucleolar protein 8 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of NOL8 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr17:14,990,394...15,013,784
Ensembl chr17:14,990,417...15,013,848
|
|
G |
Nolc1 |
nucleolar and coiled-body phosphoprotein 1 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of NOLC1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:244,921,275...244,932,089
Ensembl chr 1:244,921,377...244,932,088
|
|
G |
Nop56 |
NOP56 ribonucleoprotein |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of NOP56 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 3:117,476,963...117,481,847
Ensembl chr 3:117,477,053...117,481,841
|
|
G |
Nop58 |
NOP58 ribonucleoprotein |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of NOP58 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 9:61,120,939...61,144,810
Ensembl chr 9:61,120,929...61,144,810
|
|
G |
Nox4 |
NADPH oxidase 4 |
affects expression |
EXP |
triphenyl phosphate affects the expression of NOX4 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:140,900,886...141,078,844
Ensembl chr 1:140,901,097...141,077,406
|
|
G |
Npas2 |
neuronal PAS domain protein 2 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of NPAS2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 9:41,463,361...41,642,322
Ensembl chr 9:41,463,830...41,642,320
|
|
G |
Npy |
neuropeptide Y |
multiple interactions |
ISO |
[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in decreased expression of NPY mRNA; ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in decreased expression of NPY mRNA] |
CTD |
PMID:29112739 |
|
NCBI chr 4:78,881,294...78,888,495
Ensembl chr 4:78,881,264...78,888,495
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of NQO1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Nr0b2 |
nuclear receptor subfamily 0, group B, member 2 |
multiple interactions decreases expression |
ISO |
[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in decreased expression of NR0B2 mRNA; ESR1 gene mutant form inhibits the reaction [[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in decreased expression of NR0B2 mRNA] triphenyl phosphate results in decreased expression of NR0B2 mRNA |
CTD |
PMID:29112739 PMID:36563926 |
|
NCBI chr 5:145,779,294...145,782,609
Ensembl chr 5:145,779,294...145,782,609
|
|
G |
Nr1d1 |
nuclear receptor subfamily 1, group D, member 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of NR1D1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr10:83,728,348...83,735,562
Ensembl chr10:83,728,318...83,735,705
|
|
G |
Nr1d2 |
nuclear receptor subfamily 1, group D, member 2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of NR1D2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr15:7,524,257...7,550,553
Ensembl chr15:7,524,257...7,550,553
|
|
G |
Nr1h2 |
nuclear receptor subfamily 1, group H, member 2 |
multiple interactions |
ISO |
[Dust results in increased abundance of triphenyl phosphate] inhibits the reaction [T0901317 results in increased activity of NR1H2 protein]; triphenyl phosphate inhibits the reaction [T0901317 results in increased activity of NR1H2 protein] |
CTD |
PMID:31724879 |
|
NCBI chr 1:95,041,967...95,047,377
Ensembl chr 1:95,041,967...95,047,377
|
|
G |
Nr1h3 |
nuclear receptor subfamily 1, group H, member 3 |
multiple interactions |
ISO |
[Dust results in increased abundance of triphenyl phosphate] inhibits the reaction [T0901317 results in increased activity of NR1H3 protein]; triphenyl phosphate inhibits the reaction [T0901317 results in increased activity of NR1H3 protein] |
CTD |
PMID:31724879 |
|
NCBI chr 3:77,158,808...77,168,907
Ensembl chr 3:77,158,808...77,168,722
|
|
G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
increases expression |
ISO |
triphenyl phosphate results in increased expression of NR1H4 mRNA |
CTD |
PMID:36563926 |
|
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
increases activity multiple interactions |
ISO |
triphenyl phosphate metabolite results in increased activity of NR1I2 protein; triphenyl phosphate results in increased activity of NR1I2 protein triphenyl phosphate binds to and results in increased activity of NR1I2 protein [tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased activity of NR1I2 protein; triphenyl phosphate binds to and results in increased activity of NR1I2 protein |
CTD |
PMID:24051214 PMID:26778350 PMID:28728110 PMID:29112739 PMID:33049310 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
increases activity multiple interactions |
ISO |
triphenyl phosphate results in increased activity of NR1I3 protein [tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased activity of NR1I3 protein |
CTD |
PMID:26187274 PMID:29112739 |
|
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
|
|
G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
decreases activity multiple interactions |
ISO |
triphenyl phosphate results in decreased activity of NR3C1 protein triphenyl phosphate inhibits the reaction [Hydrocortisone results in increased activity of NR3C1 protein]; triphenyl phosphate metabolite inhibits the reaction [Hydrocortisone results in increased activity of NR3C1 protein] |
CTD |
PMID:24051214 PMID:26778350 |
|
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
|
|
G |
Nr3c2 |
nuclear receptor subfamily 3, group C, member 2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of NR3C2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr19:30,715,648...31,059,885
Ensembl chr19:30,715,648...31,059,885
|
|
G |
Nrep |
neuronal regeneration related protein |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of NREP mRNA |
CTD |
PMID:30589522 |
|
NCBI chr18:25,017,069...25,046,564
Ensembl chr18:25,017,083...25,046,591
|
|
G |
Nrg1 |
neuregulin 1 |
affects expression |
EXP |
triphenyl phosphate affects the expression of NRG1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr16:59,250,658...60,303,024
Ensembl chr16:59,250,854...60,296,884
|
|
G |
Nsg1 |
neuronal vesicle trafficking associated 1 |
decreases expression |
ISO |
triphenyl phosphate results in decreased expression of NSG1 mRNA |
CTD |
PMID:28934090 |
|
NCBI chr14:72,648,771...72,670,521
Ensembl chr14:72,648,741...72,670,514
|
|
G |
Nudt4 |
nudix hydrolase 4 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of NUDT4 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 7:30,188,100...30,204,620
Ensembl chr 7:30,188,100...30,204,615
|
|
G |
Nudt6 |
nudix hydrolase 6 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of NUDT6 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:120,289,908...120,306,197
Ensembl chr 2:120,290,847...120,306,230
|
|
G |
Nup205 |
nucleoporin 205 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of NUP205 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 4:63,854,934...63,920,852
Ensembl chr 4:63,854,783...63,920,844
|
|
G |
Oaf |
out at first homolog |
increases expression |
EXP |
triphenyl phosphate results in increased expression of OAF mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 8:43,594,362...43,612,334
Ensembl chr 8:43,594,363...43,612,334
|
|
G |
Oat |
ornithine aminotransferase |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of OAT mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:187,347,862...187,367,644
Ensembl chr 1:187,347,865...187,367,682
|
|
G |
Obp3 |
alpha-2u globulin PGCL4 |
affects expression |
EXP |
triphenyl phosphate affects the expression of OBP3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 5:74,842,316...74,845,858
Ensembl chr 5:74,842,316...74,845,757
|
|
G |
Ocln |
occludin |
decreases expression |
ISO |
triphenyl phosphate results in decreased expression of OCLN mRNA |
CTD |
PMID:35752650 |
|
NCBI chr 2:31,657,217...31,707,466
Ensembl chr 2:31,657,220...31,764,150
|
|
G |
Odf2l |
outer dense fiber of sperm tails 2-like |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ODF2L mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:234,036,049...234,072,751
Ensembl chr 2:234,033,652...234,072,747
|
|
G |
Ola1 |
Obg-like ATPase 1 |
affects expression |
EXP |
triphenyl phosphate affects the expression of OLA1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 3:57,966,896...58,085,955
Ensembl chr 3:57,966,896...58,084,480
|
|
G |
Olr59 |
olfactory receptor 59 |
affects expression |
EXP |
triphenyl phosphate affects the expression of OLR59 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:157,193,051...157,227,707
Ensembl chr 1:157,193,080...157,211,179
|
|
G |
Onecut2 |
one cut homeobox 2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ONECUT2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr18:57,831,647...57,881,287
Ensembl chr18:57,832,111...57,879,629
|
|
G |
Orm1 |
orosomucoid 1 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of ORM1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 5:76,766,637...76,776,149
Ensembl chr 5:76,772,941...76,776,154
|
|
G |
Osbpl11 |
oxysterol binding protein-like 11 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of OSBPL11 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr11:67,533,669...67,616,795
Ensembl chr11:67,533,672...67,596,444
|
|
G |
Osbpl3 |
oxysterol binding protein-like 3 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of OSBPL3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 4:79,346,583...79,523,523
Ensembl chr 4:79,350,349...79,523,393
|
|
G |
Otub2 |
OTU deubiquitinase, ubiquitin aldehyde binding 2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of OTUB2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 6:122,545,029...122,563,651
Ensembl chr 6:122,545,061...122,563,644
|
|
G |
P2ry2 |
purinergic receptor P2Y2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of P2RY2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:155,352,050...155,367,423
Ensembl chr 1:155,351,165...155,367,632
|
|
G |
Pacsin2 |
protein kinase C and casein kinase substrate in neurons 2 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of PACSIN2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 7:114,505,525...114,599,087
Ensembl chr 7:114,505,152...114,598,546
|
|
G |
Palmd |
palmdelphin |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of PALMD mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 2:204,889,526...204,941,355
Ensembl chr 2:204,889,533...204,941,519
|
|
G |
Pals1 |
protein associated with LIN7 1, MAGUK p55 family member |
increases expression |
EXP |
triphenyl phosphate results in increased expression of PALS1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 6:97,548,133...97,654,163
Ensembl chr 6:97,548,630...97,653,305
|
|
G |
Pank3 |
pantothenate kinase 3 |
increases expression |
EXP |
triphenyl phosphate results in increased expression of PANK3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr10:20,229,129...20,252,955
Ensembl chr10:20,229,129...20,252,955
|
|
G |
Papola |
poly (A) polymerase alpha |
increases expression |
EXP |
triphenyl phosphate results in increased expression of PAPOLA mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 6:124,682,015...124,734,706
Ensembl chr 6:124,682,105...124,734,468
|
|
G |
Pappa |
pappalysin |
decreases expression |
ISO |
triphenyl phosphate results in decreased expression of PAPPA mRNA |
CTD |
PMID:28282128 |
|
NCBI chr 5:78,497,660...78,735,873
Ensembl chr 5:78,498,300...78,730,666
|
|
G |
Papss2 |
3'-phosphoadenosine 5'-phosphosulfate synthase 2 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of PAPSS2 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 1:230,454,314...230,539,332
Ensembl chr 1:230,454,426...230,539,331
|
|
G |
Paqr9 |
progestin and adipoQ receptor family member 9 |
decreases expression |
EXP |
triphenyl phosphate results in decreased expression of PAQR9 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 8:96,114,249...96,116,546
|
|
G |
Pard3 |
par-3 family cell polarity regulator |
increases expression |
EXP |
triphenyl phosphate results in increased expression of PARD3 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr19:55,080,282...55,630,111
Ensembl chr19:55,080,282...55,629,778
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
affects expression |
EXP |
triphenyl phosphate affects the expression of PARP1 mRNA |
CTD |
PMID:30589522 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Patj |
PATJ, crumbs cell polarity complex component |
increases expression |
EXP |
triphenyl phosphate results in increased expression of PATJ mRNA |
CTD |
PMID:30589522 |
|
NCBI chr 5:113,061,985...113,364,807
Ensembl chr 5:113,062,118...113,364,807
|
|
G |
Pbk |
PDZ binding kinase |
affects expression |
EXP |
triphenyl phosphate affects the expression of PBK mRNA |
CTD |
PMID:30589522 |
|
NCBI chr15:40,022,873...40,034,014
Ensembl chr15:40,023,002...40,034,014
|
|
G |
Pcdh18 |
protocadherin 18 |
decreases e | |